Skip to main content
Advertisement
  • Loading metrics

Post-translational modifications of GlmR integrate metabolic and stress signals to maintain cell envelope homeostasis in Bacillus subtilis

  • Logan B. Suits ,

    Contributed equally to this work with: Logan B. Suits, Sebastian J. Khan

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Molecular Biosciences, University of South Florida, Tampa, Florida, United States of America

  • Sebastian J. Khan ,

    Contributed equally to this work with: Logan B. Suits, Sebastian J. Khan

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing

    Affiliations Department of Molecular Biosciences, University of South Florida, Tampa, Florida, United States of America, Present address: Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  • Dipanwita Bhattacharya,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Molecular Biosciences, University of South Florida, Tampa, Florida, United States of America

  • Silviya Dimitrova,

    Roles Data curation, Formal analysis, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Molecular Biosciences, University of South Florida, Tampa, Florida, United States of America

  • Prahathees J. Eswara

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    eswara@usf.edu

    Affiliations Department of Molecular Biosciences, University of South Florida, Tampa, Florida, United States of America, Center for Antimicrobial Resistance, University of South Florida, Tampa, Florida, United States of America

Abstract

The metabolic networks of most life forms integrate cost-benefit analysis to properly budget carbon and other essential nutrients. Bacillus subtilis is a Gram-positive model bacterium found in diverse ecological niches such as soil, marine environments, and the human gut. As such, B. subtilis cells fine-tune metabolic pathways by monitoring signals indicating the presence of nutrients and stressors. A highly conserved protein, GlmR, is a key player in rationing carbon for the production of cell envelope precursors. This function of GlmR can be attributed to its role in cell shape regulation and antibiotic resistance. Given its central position in carbon utilization, GlmR is under post-translational regulation by phosphorylation and UDP-N-acetylglucosamine (UDP-GlcNAc) binding. GlmR is also linked to cyclic-di-AMP (c-di-AMP), a nucleotide second messenger involved in osmotic and cell wall stress response. In this study, we probed the importance of GlmR in cell morphogenesis, c-di-AMP signaling, and investigated the physiological significance of post-translational regulation. Our results reveal that cells lacking glmR exhibit: (i) increased susceptibility to tunicamycin, a cell envelope targeting antibiotic; (ii) impaired division site positioning; and (iii) reduced intracellular c-di-AMP concentration. Furthermore, we show that the function of GlmR is fine-tuned by UDP-GlcNAc binding, phosphorylation, and acetylation. Additionally, we provide evidence showing that the recently discovered uridyltransferase activity of GlmR is integral for its function. We show that GlmR is a cell width determinant and propose a model suggesting close cooperation with an actin-like protein, MreB. Overall, our studies highlight the importance of the enzymatic function of GlmR and elucidate the mechanism behind the multiple post-translational means to regulate this crucial protein which is at the crux of carbon flux with an important role in maintaining cell envelope integrity.

Author summary

Bacteria must integrate feedback from multiple metabolic processes and environmental cues to efficiently allocate carbon to produce essential building blocks such as nucleotides, amino acids, and cell wall precursors to support life. GlmR is one such critical carbon flow regulator in diverse bacterial phyla. In Bacillus subtilis, absence of GlmR leads to abnormally large cells that are hypersensitive to cell wall targeting antibiotics. Our data reveals that the generation of cell wall precursors is an important contribution of GlmR, as growth is severely inhibited when its enzymatic function is disrupted. Based on our results, we provide a model that explains the various cell shape phenotypes previously associated with GlmR. As siphoning off too much carbon from other essential processes is detrimental to cell viability, GlmR activity is tightly regulated. In this report, we elucidate the importance of GlmR post-translational modification such as phosphorylation and lysine acetylation in calibrating carbon utilization.

Introduction

To survive and thrive, bacteria must be adept at tuning the metabolic pathways to shuttle carbon for building genetic material, cell envelope, and generating energy. This regulation must happen within seconds to assess, calibrate, and shunt metabolic intermediates to appropriate biosynthetic cycles. Post-translational regulation of metabolic proteins and the use of second messengers greatly aid in achieving this instantaneous response [1,2]. Bacillus subtilis is a common soil bacterium generally considered as the model for Gram-positive organisms [3]. Many bacteria including B. subtilis occupy and adapt to diverse ecological niches including the human gut [4] and marine environments [5]. Therefore, B. subtilis cells must skillfully tackle a multitude of challenges such as varying levels of nutrients, osmotic shifts, and other types of stressors. To achieve this, they must tightly ration carbon for different essential processes such as DNA replication, cell envelope synthesis, cell division, as well as energy production to power these tasks [6,7]. Additionally, carbon partitioning decisions should be made in conjunction with the assessment of nutrient availability and environmental threats such as those that weaken the cell envelope [8]. GlmR (formerly YvcK) is a key metabolic factor involved in carbon utilization (Fig 1A), specifically in the production of precursors needed for peptidoglycan (PG) synthesis and other cell envelope components [810]. In this report, we examine the physiological impacts of GlmR, its absence, and the various regulatory means available to calibrate its function.

thumbnail
Fig 1. GlmR plays a central role in carbon metabolism and cell shape determination.

(A) GlmR-centric metabolic pathway showing carbon flux in B. subtilis. Abbreviations: G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; FBP, fructose 1,6-bisphosphate; G3P, glyceraldehyde 3-phosphate; DHAP, dihydroxyacetone phosphate; Gro3P, glycerol-3-phosphate; PEP, phosphoenolpyruvate; Pyr, pyruvate; Ac-CoA, acetyl-coenzyme A; TCA, tricarboxylic acid; GlcN6P, glucosamine-6-phosphate; GlcN1P, glucosamine-1-phosphate; GlcNAc1P, N-acetylglucosamine-1-phosphate; UDP-GlcNAc, UDP-N-acetylglucosamine. The green lines connected to GlmR indicate direct (solid line) or indirect (dashed line) regulation and/or functions. Solid and dashed black lines represent single or multiple steps respectively. Gray arrows indicate additional pathways not discussed in detail in this article. Processes/products that utilize UDP-GlcNAc are indicated with enzymes involved listed above the arrows or within parentheses. Enzymes needed to support the uridyltransferase activity (green arrow) of GlmR are shown in bold font. The catalytic activity of GlmR requires two consecutive aspartates at position 38 and 39. GlmR is acetylated at lysine 296 using Ac-CoA directly or indirectly with the help of another protein. GlmR is phosphorylated at threonine 304 by PrkC which is believed to sense Lipid II abundance. GlmR is regulated by UDP-GlcNAc binding which requires arginine 301. The function of GlmR in stimulating GlmS is modulated by another UDP-GlcNAc binding protein YvcJ. The genes yvcJ and glmR are encoded together. Evidence linking GlmR and the nucleotide second messenger cyclic-di-AMP (c-di-AMP) exists. cdaA-cdaR-glmM genes constitute a highly conserved operon encoding genes that form a tripartite complex which determines the intracellular concentration of c-di-AMP. glmS riboswitch-ribozyme activation/inhibition is indicated. Cartoon depiction of cell morphology of B. subtilis wild type (WT) and glmR, pbp1 (ponA), and mreB deletion mutants. Deletion of pbp1 results in thinner cells while deletion of mreB leads to increased cell width when viability is maintained via magnesium supplementation. Cells lacking glmR also are abnormally large when grown in gluconeogenic conditions. The cell morphology defects of both ΔglmR and ΔmreB can be corrected by either deletion of pbp1 or by overexpression of mreB or glmR respectively.

https://doi.org/10.1371/journal.pgen.1012096.g001

Antibiotic resistance

As GlmR plays a key role in the accumulation of PG precursors, its presence becomes crucial in the presence of cell wall stress. Specifically, it has been noted that cells lacking glmR exhibit increased sensitivity to several cell wall targeting antibiotics [11,12]. This includes different classes of antibiotics that inhibit cell wall synthesis such as bacitracin, vancomycin, moenomycin, cefuroxime, and oxacillin. Thus, GlmR is a critical antibiotic resistance factor.

Cell shape

It is known that GlmR becomes essential in conditions requiring gluconeogenesis [13]. Cells lacking glmR grown in the absence of glucose exhibit abnormal morphology (Fig 1B). Therefore, ΔglmR phenotypes can be suppressed by either glucose or magnesium supplementation [12,13]. While glucose would allow glycolysis and negate the need for gluconeogenesis, the effect of magnesium is likely multifactorial. This is because magnesium supplementation may inhibit PG hydrolases [1416], deplete intracellular PG precursor levels [17], and facilitate osmoregulation [18]. Besides chemical supplementation, deletion of pbp1 (ponA), the gene encoding class A bifunctional penicillin binding protein (PBP1), also abrogates the cell morphology and viability defects of cells lacking glmR (Fig 1B) [19]. Additionally, overproduction of MreB, an actin-like cytoskeletal protein [20], also restores rod shape in ΔglmR strain [19]. Conversely, overexpression of glmR or deletion of pbp1 corrects the cell morphology defects of a strain harboring mreB deletion [19,21]. Balanced activities of MreB and PBP1 have been recognized to govern the width of the cell [22,23]. Given the reciprocal phenotypes of mreB and glmR mutants, it is possible GlmR is also a cell width determining factor. In this report we present evidence in support of this notion.

Cell wall precursor synthesis

The first step to commit carbon for the PG precursor pathway is taken by GlmS, an enzyme involved in the de novo synthesis of GlcN6P (key to abbreviations are provided in Fig 1 legend). glmS transcript abundance is self-regulated through autocleavage by a GlcN6P-responsive riboswitch-ribozyme [24]. This ribozyme activity is hindered by glucose and G6P [25,26]. Intriguingly, changes in intracellular pH and magnesium concentration may influence the activity of this ribozyme [27,28]. Alternatively, peptidoglycan can be recycled into GlcN6P to supplement this pathway [29]. Subsequently the enzymatic actions of GlmM and GlmU (GcaD) help generate the essential cell wall precursor, UDP-GlcNAc. In B. subtilis, GlmR directly interacts with GlmS and stimulates its enzymatic activity [12,30,31]. Moreover, it was shown recently that GlmR of B. subtilis and other species are in fact uridyltransferase enzymes capable of producing UDP-GlcNAc [31]. Therefore, GlmR plays a central role in carbon utilization by influencing the accumulation of UDP-GlcNAc (Fig 1A). Consequently, the flow of carbon to make PG precursors can be calibrated by regulating GlmR.

Nucleotide second messenger signaling

Past studies have linked mutations that bypass the need for glmR to increased expression of glmM and/or glmS [12]. This genetic locus harbors the highly conserved cdaA-cdaR-glmM operon (Fig 1A) [32]. CdaA is the major cyclic-di-AMP (c-di-AMP) synthase and is regulated by CdaR and GlmM in B. subtilis and other organisms [3337]. Intriguingly, disruption of c-di-AMP phosphodiesterase genes pgpH (yqfF) or gdpP (yybT) also alleviate glmR phenotypes [12,13]. Yet, the mechanism behind this remains unclear.

Post-translational regulation

GlmR binds UDP-GlcNAc, the product of its catalytic activity (Fig 1A). When UDP-GlcNAc level is in excess, this ligand binding is thought to weaken the GlmR-mediated stimulation of GlmS to establish a negative feedback loop [30,38]. Additionally, YvcJ, a RapZ-like protein encoded from the gene immediately upstream of glmR, also binds UDP-GlcNAc and interacts specifically with UDP-GlcNAc bound GlmR [30]. Besides ligand binding, GlmR (T304 residue) is also subject to phosphoregulation by PrkC [11], a S/T kinase speculated to regulate cell wall homeostasis by sensing the level of Lipid II precursors [3941]. Furthermore, a proteomics study identified that GlmR (K296 amino acid) is acetylated [42]. Metabolic intermediates such as acetyl-CoA and its derivative acetyl-phosphate are known to serve as donors of acetyl group for lysine acetylation [43,44].

In this study, we sought to investigate the new and unresolved questions regarding GlmR in antibiotic resistance, cell morphogenesis, and c-di-AMP signaling. In addition, we probed the importance of enzymatic activity, UDP-GlcNAc binding, phosphorylation, and acetylation of GlmR. Our results reveal that GlmR aids in resisting tunicamycin, an antibiotic that targets wall teichoic acids (WTA) biosynthesis selectively and the PG pathway at higher concentrations. We observe that cells lacking GlmR exhibit reproducibly larger cell width compared to the wild type (WT) control even when irregular cell morphology is corrected with chemical supplementation. Reciprocally, we see a reduction in cell width with glmR overexpression. We notice that division site positioning is impaired when glmR is deleted. We also note that c-di-AMP level is affected by GlmR in a manner dependent on CdaA. Our experiments demonstrate that the uridyltransferase activity of GlmR is essential for its cellular function, as the catalytically inactive mutant is unable to complement the ΔglmR phenotypes. Finally, we show that UDP-GlcNAc binding, phosphorylation, and lysine acetylation fine-tune GlmR activity. We provide a model based on our results to explain the role of GlmR in reversing the phenotypes of cells lacking actin-like proteins MreB and Mbl. In sum, our results shed light on the multi-level regulation of GlmR and its crucial role in cell morphogenesis and antibiotic resistance.

Results

GlmR is important for tunicamycin resistance

Given the essentiality of UDP-GlcNAc in WTA production (Fig 1A) [45], we reasoned that cells lacking GlmR may display increased susceptibility to antibiotics that target the WTA pathway, such as tunicamycin (Fig 2). The nucleoside antibiotic, tunicamycin (an analog of UDP-GlcNAc) is known to inhibit glycosyltransferases [46]. More specifically, the first step of WTA biosynthesis mediated by TagO is selectively inhibited by tunicamycin at a lower concentration range, while at a significantly higher range (>100x concentration in S. aureus [47]; > 50 µg/ml in B. subtilis [48,49]) hinders the function of MraY involved in the PG synthesis pathway (Fig 2B) [4951]. To test whether there are any changes in tunicamycin susceptibility between WT and cells lacking glmR, we conducted a disk diffusion assay encompassing a range of concentrations. Briefly, sterile disks laced with 0, 10, 25, 50, and 100 µg/ml of tunicamycin were placed on the lawns of either WT or ΔglmR strains (Fig 2A). The WT strain did not exhibit any noticeable sensitivity at 10 µg/ml and we observed a small but measurable zone of inhibition (ZOI) at 25 µg/ml. Remarkably, consistent with our prediction, we observed a larger ZOI for ΔglmR compared to WT control at all concentration ranges including 10 µg/ml, the lowest concentration tested (Fig 2A; see red arrows). The increased susceptibility of ΔglmR was abolished with glmR complementation, even in the absence of inducer likely due to leaky expression. Next, we determined the minimum inhibitory concentration (MIC) of tunicamycin in lysogeny broth (LB). Based on our assay, the MIC for WT is ~ 0.5 µg/ml (Fig 2C). This is well within the range of previous reports that show a MIC anywhere between 0.15 µg/ml to 24 µg/ml [49,5153], depending on the growth media and parental B. subtilis strain backgrounds. In contrast, we find the MIC for ΔglmR to be ~ 0.125 µg/ml which suggests that cells lacking glmR are nearly 4-fold more sensitive to tunicamycin. The resistance is restored and ~2-fold enhanced by ectopic complementation of glmR (MIC ~ 1 µg/ml). As GlmR plays a key role in supplying UDP-GlcNAc (Fig 1A) for both TagO and MraY enzymes, it is conceivable that the biogenesis of both WTA and PG (the two most important cell envelope components [54]) are dysregulated in the absence of GlmR. Thus, cells lacking glmR are ill-equipped to counter antibiotics that target these pathways. Based on our results, we add tunicamycin to yet another class of antibiotics for which sensitivity is elevated in the absence of GlmR.

thumbnail
Fig 2. Cells lacking glmR exhibit increased tunicamycin sensitivity.

(A) Disks containing 5 µl of either 0, 10, 25, 50, or 100 µg/ml tunicamycin were placed (as shown in reference; Ref) on lawns made of WT (PY79), ∆glmR (SK35), and ∆glmR complemented with IPTG-inducible glmR (SK56). Absence of GlmR leads to increased tunicamycin susceptibility, as evidenced by increased zone of inhibition (ZOI) compared to WT and the complementation strain. Quantification of the ZOI (minus the 6.5 mm disk) Also plotted are data for SK56 strain grown in the absence (leaky expression) or presence (1 mM) of IPTG. Average of four replicates is shown, and standard deviation is displayed as error bars. The red arrow indicates the lowest concentration where ZOI is observed for ∆glmR but not WT. (B) Enzymes targeted by tunicamycin. TagO, an enzyme critical for synthesizing wall teichoic acids (WTA) is selectively inhibited at lower concentration range while MraY involved in peptidoglycan (PG) synthesis is also inhibited at higher concentrations. (C) Minimum inhibitory concentration (MIC) of tunicamycin was assessed for WT (PY79), ∆glmR (SK35), and ΔglmR harboring inducible glmR (SK56) all grown in LB containing 1 mM IPTG. The triangles, circles, and squares correspond to experiments performed on different days. Error bar represents standard deviation.

https://doi.org/10.1371/journal.pgen.1012096.g002

GlmR is required for cell width maintenance

Given that glmR and mreB mutants phenocopy each other (Fig 1B), we tested whether GlmR is also involved in cell width maintenance similar to MreB. As mentioned earlier, it is known that glucose or magnesium supplementation supports ΔglmR cell viability in conditions where GlmR is otherwise essential [13]. Thus, we examined the morphology of WT and ΔglmR cells using fluorescence microscopy with or without glucose and magnesium supplementation in LB. We quantified the cell morphology changes for 4 h to cover both exponential growth phase and transition to stationary phase (Fig 3A). As expected [13], ΔglmR cells exhibited abnormal cell bulging compared to WT control in the absence of any supplementation (S1 Fig). We also observed increased incidence of aberrantly proximal and irregular septation in the ΔglmR strain with nearly 40% of septa in the field of view (n = 100) when compared to WT (<5%; n = 100) (Fig 3B and S1 Video). Thus, when GlmR is absent, the positioning of cytokinetic machinery is impaired, as evidenced by irregular septation.

thumbnail
Fig 3. GlmR is a cell width determinant.

(A) Cell length and width quantification of WT (PY79) and ∆glmR (RB176) strains grown in LB in the absence or presence of D-glucose (1%) or magnesium (25 mM MgCl2) supplementation grown for up to 4 hours and imaged at every hour. Representative micrographs are shown in S1 Fig. Individual data points and corresponding average (black line) of indicated time points post-supplementation or mock are shown (n = 100). (B) Micrographs showing normal and abnormal septation in WT (PY79) and ∆glmR (SK35) respectively. See S1 Video to view all frames of ∆glmR. Additional examples are indicated in S1 Fig with yellow arrows. Red, FM 4-64 membrane dye. Scale bar, 1 µm. (C) Representative micrographs showing WT (PY79) and ∆glmR glmR+ (SK56) uninduced or induced with 1 mM IPTG. Scale bar, 1 µm. (D) Cell width quantification of panel C data (n = 100). Cells were measured using FIJI. Statistical significance was assessed through one-way ANOVA with Tukey’s correction; **** = p < 0.0001. (E) Graphical summary depicting key observations. Although glucose or magnesium supplementation abrogates the abnormal morphology of ∆glmR cells, the average cell width is consistently larger than WT control at all time points. Additionally, we note that overexpression of glmR leads to reduced cell width and that deletion of glmR impairs division site positioning indicated as red dashed lines.

https://doi.org/10.1371/journal.pgen.1012096.g003

The cell length changes over time were consistent with previous observations for WT (Fig 3A) [55,56]. A similar trend was seen for the cells lacking GlmR. ΔglmR cells at the 3 h timepoint were longer than the WT control, which was noted previously [38]. However, by the 4 h mark this difference was diminished. In contrast to cell length, the cell width difference between WT and ΔglmR was more striking – with the latter being consistently wider. Magnesium addition corrects the abnormal ΔglmR cell morphology as reported previously [13]. We find that magnesium supplementation leads to shorter cell length at nearly all time points regardless of the strain type. This specific effect of magnesium on B. subtilis cell length has been reported previously [57]. Nonetheless, the cell width is consistently larger than WT. Although the aberrant cell morphology in the absence of GlmR is known, we expected glucose supplementation to allow glycolysis (as GlmR function is believed to be prominent only during gluconeogenesis [19]) and restore cell width similar to that of WT. However, our results reveal that ΔglmR cells are wider than WT at all timepoints even in the presence of glucose. Likewise, the post-exponential phase cell widths at 4 h were also greater than the WT control with or without supplementation. Reciprocally, unlike deletion, overexpression of glmR which presumably increases the abundance of PG precursors, leads to decreased cell width (Fig 3CD). Based on these results, we infer that GlmR is a key cell width determinant (Fig 3E), possibly through assisting PBP1 localization [19] and/or by feeding enough PG precursors to balance MreB (rod complex)/PBP1 consumption (Fig 1B).

GlmR influences the intracellular c-di-AMP level

In vegetatively growing B. subtilis, c-di-AMP synthesis occurs mainly through CdaA and DisA, which are the major and minor synthases respectively (Fig 4A) [12,36,58,59]. It is known that cells lacking both are nonviable [60,61], thus highlighting the vital role of c-di-AMP signaling. Given that mutations in the cdaA locus or deletion of c-di-AMP hydrolases allow ΔglmR phenotype suppression [12,13,62], we wished to probe the intracellular c-di-AMP level in cells lacking glmR. For this, we engineered a reporter in which gfp expression was controlled by the c-di-AMP sensing riboswitch of kimA (ydaO) promoter [6365]. Briefly, when the intracellular level of c-di-AMP drops, gfp will be transcribed and when c-di-AMP level is high gfp expression will halt (Fig 4B). Therefore, based on our design, lack of GFP indicates presence of c-di-AMP and vice versa. Similarly designed reporters have been successfully utilized for this purpose by other groups [66,67]. We introduced this reporter in the WT background as well as in strains harboring individual or combinatorial deletions of glmR and cdaA. Previous reports have found that relative to WT, deletion of disA leads to a modest decrease in intracellular c-di-AMP concentration [6770]. As our probe lacks the ability to distinguish high vs. very high levels of c-di-AMP, to enhance the sensitivity of our reporter, we also included disA deletion. In WT and ΔglmR, we did not detect a GFP band suggesting these cells maintain relatively high intracellular c-di-AMP concentration (Fig 4C). As expected, cells lacking disA produced a faint band while the cdaA knockout strain produced an intense band. Interestingly, in the strain harboring deletions of both disA and glmR genes, the faint GFP band was no longer present (Fig 4C; compare ΔdisA and ΔdisA ΔglmR lanes). This trend was consistent and reproducible even when the respective cultures were grown in the presence of glucose or magnesium. We infer this to mean that lack of GlmR, when DisA is absent, leads to stimulation of c-di-AMP production. We do not observe any noticeable changes in cdaA glmR double deletion as the GFP band intensity corresponding to this strain resembles that of cdaA knockout. Thus, the increased c-di-AMP levels we notice in ΔdisA ΔglmR strain appears to be dependent on CdaA. Next, we tested whether this stimulation requires CdaR, a known modulator of CdaA activity [36,61]. Deletion of both cdaR and glmR also produced a prominent GFP band similar to ΔcdaA and ΔglmR (Fig 4D). Our results suggest that both CdaA and CdaR are responsible for the elevated c-di-AMP levels in the ΔdisA ΔglmR strain. Therefore, it appears that the absence of GlmR in ΔdisA background leads to stimulation of c-di-AMP production through the major c-di-AMP synthase CdaA. However, as our results are derived from cells lacking either DisA or CdaA, they do not reveal the true influence that GlmR may exert on c-di-AMP level. Therefore, we used a commercial competitive Enzyme-Linked Immunosorbent Assay (ELISA) kit to directly address this (S2E Fig). We ensured the functionality of the assay using WT and ΔcdaA strains as our controls. Intriguingly, we did not see an increase in c-di-AMP level in the absence of GlmR, in fact we see a modest decrease in this second messenger concentration. This result is however in line with our PkimA-gfp reporter which suggested that both WT and ΔglmR strains contain relatively high intracellular c-di-AMP concentration. On the contrary, we see that overproduction of GlmR leads to a small but reproducibly elevated c-di-AMP level compared to WT. This is consistent with a recent report that revealed a link between high c-di-AMP concentration and reduced cell width and vice versa [67], as we also note similar cell width changes for GlmR (Fig 3E). Taken together, our results inform that GlmR level influences the intracellular concentration of the c-di-AMP second messenger in a manner dependent on CdaA.

thumbnail
Fig 4. GlmR influences the CdaA-mediated synthesis of c-di-AMP.

(A) Enzymes involved in the c-di-AMP synthesis and turnover. CdaA and DisA are the major and minor c-di-AMP synthases respectively. B. subtilis encodes a third c-di-AMP synthase, CdaS, that is activated specifically during sporulation (not indicated here). GdpP and PgpH are phosphodiesterases involved in the conversion of c-di-AMP to phosphoadenylyl-adenosine (pApA). Solid lines and dashed lines indicate the major and minor enzymes respectively. (B) C-di-AMP riboswitch reporter of kimA was used to generate a GFP-based reporter. Transcription of gfp is dependent on low intracellular c-di-AMP concentration. (C) Representative western blots of PkimA-gfp reporter in WT (SK94), ∆glmR (SK113), ∆disA (SK109), ∆cdaA (SK110), ∆disAglmR (SK111), and ∆cdaAglmR (SK112) backgrounds. All strains were grown in LB without or with supplementation of D-glucose (1%) or MgCl2 (25 mM) and harvested 2 hours after induction. Antibodies against GFP and SigA (loading control) were used to monitor the changes in PkimA-gfp reporter activity. Blue arrows indicate inferred changes in c-di-AMP levels relative to WT (↑). Red asterisk is based on results shown in S2E Fig. (D) Immunoblot of WT (SK94), ∆glmR (SK113), ∆cdaR (SK118), and ∆glmR ∆cdaR (SK119) probed with GFP or SigA antisera. The GFP/SigA ratio for all lanes relative to either ∆cdaA or ∆cdaR are shown.

https://doi.org/10.1371/journal.pgen.1012096.g004

Inspired by our results, we probed whether alterations in c-di-AMP levels influence the ΔglmR cell morphology. We find that deletion of both cdaA and glmR results in a stunning reversal of aberrant cell morphology (S2A Fig). However, as discussed in S1 Text, we attribute this to a polar effect that may synthetically elevate the expression of the downstream gene glmM of the cdaA-cdaR-glmM operon (S2BC Fig) [71,72]. Notably, suppression of ΔglmR phenotypes by increased levels of GlmM has been reported previously [12,62]. Regardless, we note that deletion of cdaA or cdaR individually or in combination with ΔglmR results in a significant drop in intracellular c-di-AMP level (Fig 4CD) - yet they all maintain normal cell shape (S2A Fig). Based on this, we conclude that reduced intracellular c-di-AMP concentration is not detrimental to cells when the cell envelope is not compromised or stressed.

We also tested whether other c-di-AMP signaling related enzymes indicated in Fig 4A influence the ∆glmR phenotypes. For this, we investigated the double deletion phenotypes of a strain devoid of glmR and the gene encoding the minor c-di-AMP synthase DisA. We also included the strains lacking GlmR and one of the two c-di-AMP phosphodiesterases GdpP or PgpH. Our experiments show that additional deletion of gdpP or pgpH, which would elevate the c-di-AMP level by limiting its turnover, is unable to correct the abnormal ∆glmR cell shape defect (S2AD Fig). So is the case with ΔdisA ΔglmR, which also increases intracellular c-di-AMP concentration (Fig 4C). However, they all appear to correct the growth phenotypes to a varying degree (S3 Fig). Our interpretations of these results and associated phenotypes are discussed in S1 Text.

The enzymatic activity of GlmR is integral for its function

GlmR was recently shown to be an uridyltransferase [31]. Therefore, we aimed to probe the physiological relevance of the enzymatic function of GlmR. To examine this, we generated strains in which ΔglmR is complemented with an inducible copy of either unmutated glmR or glmR variant harboring catalytic site mutations (D38A D39A; [31]). We then tested the growth of these strains on LB agar (LA) and Difco starch (DS) plates (Fig 5A). On LA (which contains magnesium [57]), when compared to WT, ΔglmR cells grew, albeit poorly. In contrast, on DS, while the WT strain grew well, cells lacking glmR exhibited severe growth inhibition and appear to be nearly non-viable. This medium is similar to Mueller-Hinton (MH) which is prohibitive for supporting the growth of ΔglmR strain [12]. However, we are unsure why ΔglmR cells are unable to utilize starch to support glycolysis. It is possible defective WTA may hinder the secretion of amylase needed for starch degradation [73]. Nevertheless, both the small colony phenotype on LA and lethality on DS can be reversed by glmR complementation. Thus, DS growth medium serves as a useful tool to study the functionality of GlmR mutants.

thumbnail
Fig 5. Enzymatic activity of GlmR is essential for its function.

(A) Serial dilutions of WT (PY79), ∆glmR (RB176) and ∆glmR complemented with IPTG-inducible glmR (SK56), D38A D39A glmR mutant that is catalytically inactive (BLS95), or R301A mutant which is deficient in UDP-GlcNAc binding (SK141). Representative pictures of LA and DS plates incubated overnight at 37 °C are shown. Inducer plates contain IPTG (1 mM) when indicated. (B) Micrographs of strains listed in panel A grown in LB without or with (1 mM) IPTG. Cells are labeled with FM 4-64 membrane dye (red). Scale bar, 1 μm. Arrow heads point to lysed cells. (C) Tabulated summary of data shown in panel A indicating the functionality of GlmR and speculated activity of GlmU in the indicated strain backgrounds and growth media.

https://doi.org/10.1371/journal.pgen.1012096.g005

Interestingly, we find that the D38A D39A mutant is unable to complement the ΔglmR phenotypes on LA and DS (Fig 5A). Cell morphology analysis through microscopy reveals that D38A D39A mutant is not capable of correcting the cell shape abnormality commonly seen in ΔglmR strain (Fig 5B). We used functional His-tagged GlmR to ensure that the D38A D39A mutant is stably produced (S4A Fig). Our results reveal that the catalytic activity of GlmR is required for complementation and therefore for its normal cellular function. GlmU is the primary (essential) enzyme responsible for UDP-GlcNAc production (Fig 1A). As depicted in Fig 5C, combined action of GlmU and GlmR is likely needed to support WT-like growth on LA. Thus, we see poor growth without the enzymatic function of GlmR. On the other hand, on DS medium, our results indicate that GlmR becomes the sole enzyme responsible for UDP-GlcNAc production. This notion is further strengthened by our finding that the catalytically inert mutant is unable to support the growth of ΔglmR strain.

Next, we tested whether UDP-GlcNAc binding by GlmR affects growth by making use of the R301A mutant that lacks the ability to bind to this ligand. As previously reported [12,38], R301A complements ΔglmR phenotypes. However, we note this happens on LA and DS only in the absence of inducer due to leaky expression - unlike the catalytically inert mutant (Fig 5A). However, in the presence of inducer, the phenotype is starkly different. We noticed a decrease in colony diameter on LA + IPTG and no growth on DS + IPTG. Thus, overexpression of R301A closely mimics ΔglmR phenotype in these conditions. Upon probing these cells through microscopy, we find that the cells harboring an inducible copy of R301A mutant are more similar to WT in the absence of inducer and prone to lysis in the presence of inducer (Fig 5B; see arrowheads). UDP-GlcNAc binding is proposed to promote GlmR-YvcJ interaction and thereby prevent GlmR-mediated stimulation of GlmS (Fig 1A) [30]. Therefore, it is possible that the R301A mutant may continuously stimulate GlmS (or possess enhanced enzymatic activity) which is detrimental to cell viability. Although the differential effect on YvcJ phenotype for this mutant has been noted [30], the toxic effect upon overexpression was not. This data highlights the regulatory potential of UDP-GlcNAc ligand – which is the product of the enzymatic activity of GlmR.

GlmR phosphorylation may negatively affect UDP-GlcNAc binding

GlmR is a substrate of the S/T kinase PrkC and is phosphorylated at T304 [11]. Therefore, we tested the ability of T304A (phosphoablative) and T304E (phosphomimetic) versions of GlmR to complement ΔglmR phenotypes. Our results indicate that both mutants function equivalently to unmutated glmR and complement all glmR knockout phenotypes: growth on LA and DS (S5A Fig) and restoration of cell morphology (S5B Fig). We also note that similar to glmR overexpression (Fig 3CD), overproduction of phosphomimetic or phosphoablative versions of GlmR results in cell width reduction (S5C Fig). Thus, phosphorylation does not appear to significantly influence GlmR function. This observation is consistent with previous reports [11,12]. Upon closer inspection, we do notice a modest but reproducibly smaller colony size for T304A phosphoablative mutant when compared to the GlmR control and T304E variant (S5D Fig). It has been noted that GlmR phosphomutants have differential effects on bacitracin sensitivity, correction of aberrant cell shape of ΔmreB, and PBP1 localization [11]. Thus, we aimed to further investigate the specific purpose of GlmR phosphoregulation.

Given the proximity of T304 phosphosite to R301, the residue important for UDP-GlcNAc binding, GlmR phosphorylation may influence ligand recognition [38]. Therefore, we tested this possibility with purified GlmR. For this, we used FITC-labeled protein (WT GlmR or mutants) and monitored the fluorescence change associated with ligand (UDP-GlcNAc) binding to study the binding kinetics [74]. The saturation of change in fluorescence (ΔF) associated with UDP-GlcNAc titration allowed us to estimate the dissociation constant (Kd) for GlmR as 0.28 ± 0.04 mM (Fig 6A; see inset). This value is close to 0.41 mM predicted previously [38], highlighting the reliability of this approach. In contrast, for our negative control R301A mutant, we did not notice any change in fluorescence. This confirms that R301A mutant is unable to bind UDP-GlcNAc as established previously [38]. For T304A mutant, our estimated Kd value is 1.67 ± 0.31 mM, which is in a similar range to GlmR control. On the contrary, for T304E mutant, ΔF saturation was not achieved even with 5 mM UDP-GlcNAc, which precluded us from calculating the Kd value. We infer this result to mean that UDP-GlcNAc binding is possibly weaker and/or more transient when GlmR is in a phosphomimetic state (Fig 6B). Overall, our results indicate that GlmR phosphorylation may render UDP-GlcNAc binding less favorable (Fig 6C). As PrkC is involved in the regulation of cell envelope synthesis and is important for resisting cell wall targeting antibiotics [3941], GlmR phosphorylation may be used by cells to temporarily and reversibly override self-inhibition by UDP-GlcNAc accumulation to accelerate PG precursor production and strengthen the cell envelope.

thumbnail
Fig 6. Phosphorylation of GlmR may weaken UDP-GlcNAc binding.

(A) The binding of UDP-GlcNAc to purified WT GlmR, GlmR T304A, GlmR T304E, or GlmR R301A were monitored using fluorescence spectroscopy. Shown are the representative fluorescence spectra of FITC-labeled GlmR or mutants (5 µM) were incubated without (●) or with UDP-GlcNAc at 0.5 mM (○), 1.0 mM (■), 1.5 mM (□), 2.0 mM (▲), 2.5 mM (△), 3.0 mM (◆), 3.5 mM (◇), 4.0 mM (▼), 4.5 mM (▽) and 5.0 mM (⬡) concentrations. Inset, binding constants (Kd) were calculated by plotting the difference in fluorescence intensities (ΔFmax) at different ligand concentrations when saturation was achieved. ND, not determined. (B) The fluorescence maxima of GlmR (●), T304A (■), T304E (▲), and R301A (◆) are plotted; n = 3, ** and **** indicate p < 0.0084 and 0.0001, respectively. (C) Inference model based on the results shown in panel A indicating that phosphoregulation of residue T304 may alter the kinetics of UDP-GlcNAc ligand binding.

https://doi.org/10.1371/journal.pgen.1012096.g006

GlmR function is likely affected by acetylation

In addition to phosphorylation, GlmR (also known as MgfK) is subject to another post-translational modification through lysine acetylation at position 296 [42]. Several other metabolic enzymes shown in Fig 1A, including GlmS, GlmM, GlmU, and YvcJ are also acetylated [42,43,75,76]. Acetylation is known to regulate catalysis, influence protein structure, and alter partner preference between proteins [77]. Therefore, we aimed to study whether lysine acetylation influences GlmR function. To investigate this, we mutated K296 to either glutamine to mimic acetylation or arginine to resemble an unacetylated residue as previously described [42]. As shown in Fig 7A, K296Q acetyl-mimetic mutant was able to complement ΔglmR phenotypes in LA and DS similar to the glmR control. In contrast, while K296R acetyl-ablative mutant was able to complement in the absence of inducer, overexpression resulted in significant growth inhibition (Fig 7A; see + IPTG plates). Microscopy analysis revealed that K296Q acetyl-mimetic mutant corrected the abnormal ΔglmR cell morphology, similar to the unmutated glmR control (Fig 7B). On the other hand, K296R acetyl-ablative mutant prevented the cell bulging phenotype of ΔglmR only in the absence of inducer. In the presence of inducer, we observed increased cell lysis (Fig 7B; see arrowheads). Thus, it appears that acetylation may also moderate the activity of GlmR by possibly hindering UDP-GlcNAc binding as these observations resemble the phenotypes of R301A variant (Fig 5). Taking the proximity of the sites important for UDP-GlcNAc binding (R301) and phosphorylation (T304) and our results into account, we propose that acetylation of GlmR (K296) likely negatively affects the flow of carbon to the PG precursor pathway. Conversely, we believe deacetylation and phosphorylation may promote UDP-GlcNAc synthesis (Fig 8A).

thumbnail
Fig 7. GlmR function is moderated by acetylation.

(A) Spot titers of WT (PY79), ∆glmR (RB176) and ∆glmR complemented with IPTG-inducible glmR (SK29), K296Q glmR mutant to mimic acetylation (SK107), or K296R glmR mutant to mimic unacetylated status (SK108). Representative plate pictures of the above-mentioned strains grown in LA or DS medium at 37 °C overnight are shown. Inducer plates contain IPTG (1 mM). (B) Fluorescence micrographs of strains listed in panel A grown in LB in the absence or presence IPTG (1 mM). Cell membrane is stained with FM 4-64 dye (red). Scale bar, 1 μm. Arrowheads indicate cell lysis.

https://doi.org/10.1371/journal.pgen.1012096.g007

thumbnail
Fig 8. Graphical summary and illustration of proposed models.

(A) In B. subtilis, GlmU is the main bifunctional essential enzyme that generates UDP-GlcNAc. In this report, we show that the uridyltransferase activity of GlmR is also critical to supplement UDP-GlcNAc synthesis. We also reveal that UDP-GlcNAc binding inhibits the catalytic activity of GlmR. While lysine acetylation (Ac) promotes this inhibition, phosphorylation appears to weaken UDP-GlcNAc binding and thus may prevent self-inhibition. (B) De novo amino sugar biosynthetic pathway involved in UDP-GlcNAc production. We predict that GlmM inhibition of CdaA is moderate when the forward reaction is effective such as when GlmR is present. In the absence of GlmR, we speculate carbon flow in this pathway is decreased. This signal is transduced through increased inhibition of CdaA by GlmM. This decreased CdaA activity contributes to a modest drop in intracellular c-di-AMP concentration. SH labels on GlmU indicate two redox-sensitive cysteines that negatively affect its acetyltransferase activity in non-reducing conditions. (C) Speculative model depicting the main UDP-GlcNAc utilization pathways. The actin-like proteins MreB, MreBH, and Mbl assist with RodA/class B PBP machinery; PBP1 is a class A bifunctional enzyme. MreB/MreBH control cell width. Mbl is believed to monitor cell elongation. PBP1 is considered a general-purpose cell wall repair enzyme. Proper deployment of these four pathways is critical for cell width regulation. (D) In the absence of GlmR, we predict less accumulation of UDP-GlcNAc. We believe that this specifically impairs MreB pathway (see S6 Fig). (E) We suspect that overproduction of GlmR leads to elevated UDP-GlcNAc level which is specifically consumed through the MreB pathway. Hence, the decrease in cell width we observe in cells overexpressing glmR (Fig 3). Arrows: dashed and increased thickness are used to indicate weak and strong flow/consumption/interaction respectively.

https://doi.org/10.1371/journal.pgen.1012096.g008

Discussion

Antibiotic resistance

The enzymatic role of GlmR in drawing carbon for UDP-GlcNAc synthesis is now evident (Fig 8AB). As such, cells devoid of glmR are incapable of mounting a proper response to host immune factors and cell wall targeting antibiotics [11,12,31,7880]. Given that UDP-GlcNAc is also an essential component of the WTA pathway, we show that cells lacking glmR are highly sensitive to tunicamycin (Fig 2), a dual-function antibiotic that preferentially targets WTA at lower concentrations and PG biosynthesis at higher concentrations.

Cell morphogenesis

The push and pull of PBP1 and MreB (rod complex) activities determine the cell width of B. subtilis cells [2123]. The similarities between glmR and mreB phenotypes hinted at an analogous role for GlmR (Fig 1B). We now confirm that GlmR is a key cell width determinant (Fig 3E). Besides MreB, B. subtilis encodes two additional MreB-like proteins Mbl and MreBH (Figs 8C and S6A) [20,81]. Although mreB and mbl are essential and mreBH is not, the essentiality could be reversed in certain growth or genetic conditions [81]. While MreB and MreBH play a role in the same pathway to achieve cell width control, Mbl is involved in an independent but parallel pathway to facilitate cell elongation [82,83]. In a high-throughput CRISPR-based analysis, it was recently found that mbl can be rendered non-essential in the absence of glmR [84]. This is in direct contrast to MreB, where glmR overexpression supports the viability of cells lacking mreB (Fig 1B) [19]. Thus, it may be reasoned that GlmR differentially modulates MreB, Mbl, and PBP1 functions. However, based on the enzymatic function of GlmR, we speculate that the differences in synthetic essentiality are likely due to the different rate of PG precursor consumption and/or PG hydrolysis in these mutants, which can be supported by either glmR deletion (for Δmbl) or overexpression (for ΔmreB). In the absence of GlmR, we expect a reduction in UDP-GlcNAc level (Fig 8B), which disproportionately affects the MreB pathway of elongasome machinery (Fig 8D). This is supported by the finding that only overexpression of mreB restores the cell morphology defects of cells lacking glmR - but not mbl or mreBH [19]. Upon GlmR overproduction, we predict that UDP-GlcNAc level would be elevated and specifically favors MreB pathway, thus leading to decreased cell width (Fig 8E).

Another genetic condition that leads to ΔglmR cell shape restoration is deletion of pbp1 (Fig 1B) [19]. Eliminating the consumption of UDP-GlcNAc by PBP1 likely frees up this precursor for MreB. Additionally, pbp1 deletion triggers alternative sigma factor SigI activation and consequently upregulation of mreBH ensues (S6AB Fig) [85]. This likely reinforces UDP-GlcNAc utilization by the collaborative MreB/MreBH pathway [82]. This may also explain why deletion of pbp1 or SigI activation suppresses the aberrant cell shape defects of both mreB and mbl knockout strains [81,86]. As depicted in S6A Fig, the morphology of cells lacking mbl is quite distinct from ΔmreB mutant [8789]. In the extended discussion (see S1 Text), we use our working model to explain this peculiar Δmbl phenotype, why deletion of glmR renders mbl non-essential, and why glucose and magnesium supplementation fail to restore the cell width of ΔglmR cells to resemble WT (Fig 3E). Overall, we believe that GlmR dictates the cell width by supplying UDP-GlcNAc to bolster MreB activity. Of note, we find that ΔglmR cells exhibit increased sensitivity to tunicamycin an antibiotic that targets the WTA pathway (Fig 2). It is shown that the MreB-containing rod complex is specifically inhibited by tunicamycin and that PBP1 activity becomes more important in these cells [49]. Thus, the cell bulging that happens when WTA production is inhibited by either deletion of tagO [90] or tunicamycin treatment [91] is possibly due to hindered MreB activity and increased PBP1 function (Fig 8D). We do note that our rather simplistic model does not take other factors with known role in cell shape regulation into account [83,9295]. Thus, further model refinement is warranted when more information regarding GlmR comes to light.

Cytokinesis

We observed that the positioning of cytokinetic machinery is impaired when GlmR is absent (Fig 3B). The underlying mechanism for this is unclear at the moment. Specifically, how division site positioning systems are bypassed needs to be investigated. It is possible that altered carbon metabolism, turgor pressure, cell morphology, and/or membrane fluidity may lead to aberrant cytokinesis [7,9699]. Alternatively, it could be due to decreased WTA composition as cells lacking tagO also exhibit aberrant septation [90].

Connections to c-di-AMP

In B. subtilis and other organisms, GlmM inhibits CdaA (Fig 8B) [3337]. GlmR increases the substrate availability for GlmM by stimulating GlmS. GlmR also contributes to the removal of the product made by GlmM (GlcN1P) to generate UDP-GlcNAc. Thus, it is conceivable that both actions of GlmR would promote the enzymatic function of GlmM to favor the forward reaction. We suspect that this may in turn result in weaker inhibition of CdaA activity, which allows WT cells to maintain a relatively high intracellular c-di-AMP concentration (Fig 4). This argument is strengthened by our result showing GlmR overproduction leads to increased c-di-AMP level (S2E Fig). Conversely, absence of GlmR would result in GlmM idling longer (or performing the reverse reaction) which may promote GlmM dependent CdaA inhibition (Fig 8B) and consequently lead to decreased c-di-AMP concentration. Thus, this nucleotide second messenger may be used by the cells to broadcast the status of GlmM function. Instead (or in addition), changes in turgor pressure due to a weakened cell wall [67], which we observe in ΔglmR strain manifested by abnormal cell morphology, could lead to altered enzymatic activity of CdaA. Therefore, the cytoplasmic regulation of CdaA by GlmM combined with the extra-cytoplasmic regulation of CdaA by CdaR (Fig 4C), both detecting flawed cell wall synthesis in the absence of GlmR function may negatively affect c-di-AMP level [61,67,100]. We find that increased expression of glmM in ΔglmR is sufficient to support WT-like growth and cell morphology even when cdaA is deleted (S2C Fig). Thus, we can postulate that the reduction of intracellular c-di-AMP level is not deleterious by itself and may signify when the cell envelope needs reinforcement such as when the PG precursor pathway is inhibited or in the presence of cell wall stressors.

One of the main functions of c-di-AMP is to regulate potassium influx/efflux for osmoregulation [18,101109]. We elaborate on the possible implications in the extended discussion provided in S1 Text. Additionally, secreted c-di-AMP [69] and/or stringent response activation [110114] may influence metabolic pathways in the absence of GlmR. Thus, further experiments are needed to test these possibilities.

Enzymatic activity

GlmR and its homologs possess uridyltransferase activity to synthesize UDP-GlcNAc (Fig 8A) [31]. We show that the catalytic function of GlmR is: (i) essential for growth on DS, (ii) required to support WT-like growth on LA, and (iii) necessary to correct ΔglmR cell morphology defects (Fig 5). The B. subtilis GlmU (GcaD; an essential protein) has both acetyltransferase [115] and uridyltransferase [116] functions to generate N-acetyl glucosamine-1-phosphate (GlcNAc-1P) and UDP-GlcNAc respectively (Figs 1A and 8AB). Based on our results, we can infer that on DS, the uridyltransferase activity of GlmU is disabled and cells exclusively depend on GlmR (Fig 5C). Could GlmR perform both functions of GlmU? This possibility was ruled out in an in vitro experiment with purified L. monocytogenes GlmR [31]. Whether in vivo acetylation of GlmR (Fig 7) allows for it to be an acetyltransferase remains to be seen. The key lysine residue is mutated in both acetyl-mimetic (K296Q) and acetyl-ablative (K296R) mutants of GlmR, yet they complement ΔglmR phenotypes. Thus, perhaps one of the acetylated partners of GlmR such as YvcJ may serve as an acetyl donor. Intriguingly, the morphogenetic protein MreB (discussed above) is also acetylated at three different residues and the acetyl-ablative mutation of one of the lysines impairs cell morphology control [42]. Additional experiments are necessary to investigate these models.

In Mycobacterium tuberculosis, phosphorylation of GlmU by an S/T kinase was found to negatively affect the acetyltransferase activity but not uridyltransferase activity [117]. Thus, one of the two functions of GlmU could be specifically deactivated by post-translational modification. It was found that glmU gene expression is downregulated during stringent response [118,119]. The production of stringent response alarmone, (p)ppGpp, can be elicited by a c-di-AMP binding protein, DarB [112]. As we observed GlmR-mediated fluctuations in c-di-AMP concentration (Figs 4 and S2E), perhaps on DS medium glmU transcription is repressed by stringent response activation. Pyruvate kinase is another metabolic enzyme with link to stringent response [120], which is differentially autoregulated in glycolytic vs gluconeogenic conditions [121]. Thus, it is possible that GlmU activity is affected similarly. Additionally, conditions such as high magnesium and low pH hinder the acetyltransferase activity of B. subtilis GlmU [115]. Intriguingly, alteration in c-di-AMP levels is also known to modulate intracellular magnesium concentration [18]. Moreover, it has been found that GlmU is regulated by two cysteine residues that are involved in disulfide bond formation and therefore responsive to intracellular redox status (Fig 8B) [115,122]. Specifically, acetyltransferase activity was found to be diminished in non-reducing conditions. It is therefore plausible that the intracellular conditions of ΔglmR mutant in DS growth medium are not optimal for one or both enzymatic function(s) of GlmU. Intriguingly, UDP-GlcNAc is also essential for bacillithiol production (Fig 1A). Bacillithiol is an important agent involved in redox stress response as well as a resistance factor for cell wall targeting antibiotics [123]. Therefore, it is tempting to speculate that in the absence of GlmR cells are unable to properly respond to oxidative stress. However, overexpression of glmS/glmM (S2BC Fig) appears to fully restore GlmU activity perhaps by alleviating oxidative stress. Alternatively, the cause of death of ΔglmR cells and failure to complement by enzymatically inert mutant could be indirect. For example, this mutant may fail to stimulate GlmS and draw carbon for GlmU to execute its function (Fig 8B). Experiments to test these speculations are underway.

Phosphorylation

Prior to the knowledge of its uridyltransferase activity, GlmR was shown to bind UDP-GlcNAc. The mutants defective in binding UDP-GlcNAc did not exhibit any noticeable phenotype [12,38]. However, we show that the binding of UDP-GlcNAc ligand moderates GlmR function (Fig 8A) as overproduction of UDP-GlcNAc binding deficient variant (R301A) is toxic (Fig 6AB). Similarly, phosphoregulation of GlmR and its physiological importance have been investigated previously [11,12]. GlmR mutants either mimicking phosphorylated or unphosphorylated state support growth. PrkC, the kinase responsible for phosphorylating GlmR, is known to sense cell wall stress and/or the changes in the levels of PG precursors and fine-tune growth rate accordingly [3941,124]. Thus, it is possible that phosphorylation of GlmR may serve to prioritize carbon for strengthening the cell envelope through boosting UDP-GlcNAc level. Subsequently, the removal of phosphate by PrpC phosphatase may lower the function back to basal level but not completely off - this would explain why phosphoablative mutant is also able to complement. Results of our in vitro experiments suggest that phosphorylation may hinder but not abolish UDP-GlcNAc binding (Fig 8A). Intriguingly, while overexpression of the mutant deficient in recognizing UDP-GlcNAc (R301A) is toxic, phosphomimetic mutant (T304E) where UDP-GlcNAc binding appears to be more transient is not. However, GlmR is subject to multiple levels of regulation within the cell that cannot be incorporated with purified proteins. As only phosphomimetic version of GlmR supports rod shape maintenance in ΔmreB [11], we could envision a scenario where phosphorylation increases UDP-GlcNAc synthesis and support Mbl/MreBH pathway to counteract the action of PBP1 (Fig 8C). On the contrary, phosphoablative mutant is unable to sufficiently elevate the UDP-GlcNAc level in ΔmreB strain background to support rod shape maintenance. Alternatively, as MreB and PBP1 form a complex [21] and GlmR assists in PBP1 localization [11,19], perhaps GlmR phosphorylation alters the partner preference. Further investigation is required to test these hypotheses.

Acetylation

Similar to phosphorylation, acetylation of lysine residues serves as another reversible post-translational regulatory mechanism [77]. A handful of proteomics studies have identified acetylated proteins in B. subtilis [42,43,75,76]. GlmR is found to be acetylated along with several other proteins including GlmS, GlmM, GlmU, and YvcJ discussed in this report (Fig 1A). Therefore, we investigated whether acetylation influences GlmR function. Our results revealed that GlmR acetyl-mimetic (K296Q) mutant was equally efficient as WT copy in complementing glmR phenotypes. However, acetyl-ablative GlmR mutant (K296R) was toxic upon overexpression similar to the mutant (R301A) that is unable to bind UDP-GlcNAc. Based on our results, it appears that acetylation of lysine 296 of GlmR may serve to negatively regulate its enzymatic activity (Fig 8A). Interestingly, the equivalent residue is naturally glutamine in Bacillus halodurans and based on the crystal structure (PDB ID: 2O2Z) it does not appear to be involved in the coordination of its ligand, NAD in this case [38]. However, this loop-like region is not clearly resolved in the crystal structure and is possibly dynamic. In Staphylococcus aureus and Listeria monocytogenes, the corresponding residue appears to be aspartate and glutamate respectively [31]. Our heterologous complementation experiment suggests that S. aureus GlmR (Sa GlmR) exhibits uridyltransferase activity in vivo as it complements B. subtilis ΔglmR strain (S4C Fig). This is consistent with a previous finding [31]. Intriguingly, we see that the overproduction phenotype of Sa GlmR resembles that of B. subtilis K296R acetyl-ablative mutant (Fig 7A). Nonetheless, other proximal lysine residues are present in GlmR homologs, and may be acetylated in the corresponding host organism. Therefore, acetylation is likely an additional post-translational mechanism that fine-tunes the function of GlmR [125127]. Besides acetylation, GlmR appears to be also subject to succinylation and malonylation [76]. Thus, multiple modes of regulation may exist.

Conservation of GlmR and its potential as drug target

Our findings about B. subtilis GlmR are likely broadly applicable to its homologs in other organisms which include several clinically relevant pathogens. GlmR is highly conserved in diverse bacterial lineages and in some archaea [13,30]. However, except for Gram-positive bacteria not much is known about the function of GlmR-like proteins in other organisms. In M. tuberculosis (CuvA/Rv1422), it is found to accumulate at sites of active cell wall synthesis and contribute to virulence [78]. It is also found to be phosphorylated by an S/T kinase in this organism [128]. L. monocytogenes GlmR is important for survival within the host during infection, and it is also phosphorylated by an S/T kinase [79]. In S. aureus, glmR is an essential gene [129,130]. However, another study indicates that glmR mutant is temperature sensitive [131]. A link between GlmR, S/T kinase, and CdaA appears to exist in S. aureus as well [132]. Enterococcus faecalis GlmR phenotype differs from that of its B. subtilis counterpart [80]. Nevertheless, it binds to UDP-GlcNAc and plays a role in antibiotic resistance. GlmR homologs of the above-mentioned organisms are enzymatically active and produce UDP-GlcNAc [31,80]. The specific function of E. coli homolog (YbhK) is yet to be characterized. However, yhbK of E. coli was found to complement glmR in B. subtilis – thus it may play a similar enzymatic function in its host organism as well [13]. Disruption of yhbK is associated with increased tolerance to the cell wall targeting antibiotic ampicillin [133]. Intriguingly, GlmR in Salmonella enterica is regulated via glycosylation, specifically with GlcNAc addition to an arginine [134]. Thus, additional experiments are needed to uncover the full scope of the regulatory modes of GlmR and other related pathways. Given its crucial role in antibiotic resistance and pathogenesis, inhibitors of GlmR enzyme could be developed as novel therapeutics.

Summary

B. subtilis is an excellent model to investigate fundamental biological pathways. Additionally, it is also a widely used bacterium in various biotechnology industries [3,135]. Thus, deeper understanding of metabolic processes would propel the fields of both basic and applied biology. In this report, we show that GlmR is a central metabolic enzyme which is regulated by multiple means. More specifically our results suggest that post-translational regulation of GlmR may aid in decisions involving carbon prioritization. This role becomes vital in times of cell envelope stress. Therefore, unsurprisingly, cells lacking glmR are highly susceptible to cell envelope targeting antibiotics. As antibiotic resistance is a growing concern worldwide, key metabolic pathways and proteins such as GlmR could serve as potential therapeutic targets [122,136139].

Materials and methods

Strain construction

B. subtilis strains utilized in this study are derivatives of PY79 [140]. Specific details regarding strain construction can be found in S1 Text. All strains and oligonucleotides referenced are listed in Tables A and B in S1 Text respectively. The knockout strains were obtained from the Bacillus Genetic Stock Center [141]. Plasmids pDG1662 [142], pDR111 (David Rudner), pDR244 [141,143], and pBS2EXylRPxylA (ECE741; [144]) were used to create strains for this study. pET28a vector was used for purifying recombinant B. subtilis GlmR and its mutants from E. coli. QuikChange kit (Agilent) was used for site-directed mutagenesis. All plasmids generated were verified through Sanger or whole plasmid sequencing (Azenta). All B. subtilis chromosomal gene deletions and insertions were confirmed via PCR and other standard techniques.

Media used and spot titer assay

Overnight cultures grown at 30 °C in lysogeny broth (LB Miller; Fisher Scientific) were serially diluted up to 10-5 and 1 µl of culture was plated on LB agar (LA; Fisher Scientific) or BD Difco Starch agar (DS) plates containing either 0 or 1 mM IPTG. Plates were imaged after overnight incubation at 37 °C.

Antibiotic susceptibility testing

Zone of inhibition (ZOI) assays were completed after overnight cultures of the indicated B. subtilis strains were grown in LB at 30 °C. Cultures were standardized to an OD600 of 0.1 and 100 µl was spread using sterile glass beads on LA plates. Plates were allowed to dry with their lid off for 30 minutes in a biosafety cabinet. Plates with sterile filter paper disks laced with 5 µl of 0, 10, 25, 50, or 100 µg/ml tunicamycin (Sigma) were incubated overnight at 37 °C. ZOI diameter quantification was performed via FIJI [145]. The standard diameter of the filter paper disks (6.5 mm) was subtracted from all ZOI measurements.

Minimum inhibitory concentration (MIC) assessment

Overnight cultures of strains grown at 30 °C in LB were diluted to an OD600 of 0.01 in 100 µl LB supplemented with 1 mM IPTG. Tunicamycin antibiotic was added to the top row of a 96-well plate and serially diluted down the plate in 2-fold increments. Strains were grown overnight in a 96-well plate at 37 °C in a shaking incubator. The MIC concentration was estimated based on the well with lowest antibiotic concentration that had no growth.

Western blot

Immunoblot analysis of indicated strains were completed after overnight cultures of B. subtilis strains grown in LB at 30 °C were diluted to an OD600 of 0.05 in 10 ml of LB. When indicated, cultures were supplemented with a final concentration of 25 mM MgCl2, 1% glucose, or 1 mM IPTG. Cultures were grown to an OD600 of ~1, standardized to an OD600 of exactly 1 before centrifugation and resuspension in protoplast buffer containing 0.5 M sucrose, 20 mM MgCl2, 10 mM KH2PO4, and 0.1 mg/ml lysozyme. Samples were incubated at 37 °C for 30 min and then prepared for SDS-PAGE. After electrophoresis, the samples were transferred onto a nitrocellulose membrane and subsequently probed with appropriate antibodies.

C-di-AMP enzyme-linked immunosorbent assay (ELISA)

Overnight cultures grown at 30 °C in LB were diluted to an OD600 of 0.1 in LB supplemented with 1 mM IPTG. The freshly inoculated strains were grown to an OD600 of approximately 1.0 and standardized. A culture aliquot of 1 ml was centrifuged and resuspended in 0.5 ml of protoplast buffer containing 0.5 M sucrose, 20 mM MgCl2, 10 mM KH2PO4, and 0.1 mg/ml lysozyme. Samples were incubated at 37 °C for 30 min and then diluted 50-fold in sterile water to lyse cells. Immediately after this step, ELISA assay was performed according to the manufacturer instructions provided in the kit (Cayman Chemicals). This kit was a kind gift from the laboratory of Dr. Wenqi Yu (USF). All samples were measured in triplicates and read at OD450 on a Tecan Infinite 200 PRO plate reader. Analysis was completed in Microsoft Excel and GraphPad Prism 10.

Microscopy

Overnight cultures of B. subtilis strains grown at 30 °C in LB were diluted to an OD600 of 0.05 in 10 ml LB. If noted, cultures were made to a final concentration of 25 mM MgCl2, 1% glucose, or 1 mM IPTG. For the time course microscopy, cultures were grown for the duration indicated. For all other experiments, cultures were grown to an OD600 of 1 at 37 °C. Sample preparation and microscopy techniques were completed as previously described [146]. DeltaVision Elite high-resolution deconvolution fluorescence microscope equipped with Photometrics CoolSnap HQ2 camera was used for imaging. Manufacturer-provided SoftWorx software was used for image processing.

Quantification and statistics

Analysis of ZOI, colony size, and measurements of cell length/width were performed using FIJI [145]. Statistical analysis was conducted using GraphPad Prism version 10.4.1. Ordinary one-way ANOVA with multiple comparisons was used with Tukey’s post-correction.

Biochemical analysis

For labeling WT and mutant forms of GlmR, the purified proteins were labeled with fluorescein isothiocyanate (FITC) as previously reported [74]. Briefly, 50 µM of each WT-GlmR and mutants were incubated with FITC (250 µM) in 50 mM phosphate buffer (pH 8.0) for 5 h on ice. The reaction was stopped by adding 5 mM Tris-HCl (pH 8.0). Sephadex G25 fine column (Cytiva) was used to separate the free FITC from the labeled proteins. The concentrations of FITC-bound GlmR and mutants were determined by absorbance at 495 nm. The concentrations of the proteins were measured using Bradford assay. The stoichiometry of labeling FITC per GlmR and mutant constructs was found to be approximately 0.6. The dissociation constant (Kd) was determined by titrating UDP-GlcNAc ligand (L) and measuring the change in FITC-labeled protein fluorescence (ΔF). The following single-site binding equation was used for Kd estimation: ΔF = (ΔFmax· [L])/ (Kd + [L]).

Supporting information

S1 Text. Supplemental Results and Discussion Topics.

Rescue of ΔglmR phenotypes by additional deletion of cdaA is likely due to polar effect. Deletion of gdpP, pgpH, or disA enhances the growth of ΔglmR mutant. Role of GlmR in cell morphogenesis. Potential role for potassium. Supplemental Methods. Table A: Strains used in this study. Table B: Primers used in this study. III. Supplemental.

https://doi.org/10.1371/journal.pgen.1012096.s001

(DOCX)

S1 Fig. GlmR is important for correct cell shape and septation.

Representative micrographs of WT (PY79) and ∆glmR (RB176) strains grown in LB in the absence or presence of D-glucose (1%) or magnesium (25 mM MgCl2) supplementation, imaged hourly for four hours. Yellow arrows indicate examples of abnormal septation.

https://doi.org/10.1371/journal.pgen.1012096.s002

(TIF)

S2 Fig. Deletion of cdaA rescues ∆glmR phenotype likely due to polar effect.

(A) Fluorescence micrographs of membrane-stained (FM 4–64, red): WT (PY79), ∆glmR (RB176), ∆disA (SK97), ∆disA ∆glmR (SK102), ∆cdaA (SK97), ∆cdaA ∆glmR (SK101) ∆cdaR (SK130), or ∆cdaR ∆glmR (SK131). Scale bar, 1 μm. (B) Genetic locus of cdaA-cdaR-glmM operon. Genes sigW-rsiW are located upstream of this operon while glmS is present immediately downstream in the B. subtilis genome. Red asterisks indicate the position of mutations commonly found in the ∆glmR suppressors that allow increased transcription of cdaA-cdaR-glmM genes and/or glmS. The terminator downstream of this cdaA operon is weaker (depicted with shorter symbol) resulting in read-through transcription of glmS. glmS has its own promoter followed by a riboswitch-ribozyme [71,72]. Replacement of cdaA or cdaR with an antibiotic resistance cassette introduces additional promoter (shown in red) and removal of the cassette replacing cdaA (∆cdaA*; markerless) brings glmM closer to its native promoter, thus potentially result in stronger expression. (C) Fluorescence micrographs of membrane-stained (FM 4–64, red): WT (PY79), ∆glmR (RB176), ∆glmR ∆cdaA* (SK138), and ∆glmR ∆cdaA* with inducible glmM+ (BLS67). When indicated, 0 and 1 mM IPTG was used in IPTG (-) and (+) conditions respectively. Scale bar, 1 μm. (D) Representative micrographs of WT (PY79), ∆glmR (RB176), ∆gdpP (SK98), ∆pgpH (SK99), ∆glmR ∆gdpP (SK103), and ∆glmR ∆pgpH (SK104). Red, FM 4–64 membrane stain. Scale bar, 1 µm. (E) ELISA-based intracellular c-di-AMP concentration estimation of WT (PY79), ∆glmR (SK35), ∆glmR complemented with inducible glmR (SK56), and ∆cdaA (SK130). Filled black circles represent technical replicates; error bars represent standard deviation.

https://doi.org/10.1371/journal.pgen.1012096.s003

(TIF)

S3 Fig. Single deletions of genes related to c-di-AMP.

(A) Serial dilutions of WT (PY79), ∆glmR (SK35), ∆glmR glmS+ (BLS84) on LA, LA + 3% xylose, DS, or DS + 3% xylose. (B) Serial dilutions of WT (PY79), ∆glmR (RB176), ∆glmR ∆cdaA (SK101), ∆glmR ∆cdaA* (SK138), and ∆glmR ∆cdaA* glmM+ (BLS67) on LA, LA + 1 mM IPTG, DS, or DS + 1 mM IPTG. (C) Spot titer assay of WT (PY79), ∆glmR (SK35), ∆cdaA (SK96), ∆cdaA* (SK137), ∆gdpP (SK98), and ∆pgpH (SK99) on LA and DS. (D) Growth of serially-diluted culture aliquots of WT (PY79), ∆glmR (RB176), ∆glmRgdpP (SK103), and ∆glmRpgpH (SK104) on LA and DS plates. (E) Spot titer assay showing growth of WT (PY79), ∆glmR (RB176), ∆disA (SK97), and ∆glmR ∆disA (SK102) on LA and DS plates.

https://doi.org/10.1371/journal.pgen.1012096.s004

(TIF)

S4 Fig. Complementation assessment of B. subtilis GlmR mutants and S. aureus GlmR.

(A) Serial dilutions of WT (PY79), ∆glmR (SK35), ∆glmR glmR+ (SK56), ∆glmR glmR-6his+ (BLS101), and ∆glmR glmR-D38A-D39A-6his+ (BLS102) on LA, LA + 1 mM IPTG, DS, or DS + 1 mM IPTG. (B) Representative western blot of ∆glmR glmR-6his+ (BLS101) and ∆glmR glmR-D38A-D39A-6his+ (BLS102) with IPTG (1 mM) induction probed with anti-His antibody. Ponceau S-stained total protein gel for both samples serves as loading control. (C) Spot titer analysis to test the ability of S. aureus glmR (glmRSa) to complement B. subtilisglmR heterologously. The growth of WT (PY79), ∆glmR (SK35), ∆glmR glmRBs (SK56), ∆glmR glmRSa (SK27), and glmRSa (SK23) on LA and DS plates (containing 1 mM IPTG when indicated) were studied. Representative pictures of plates incubated overnight at 37 °C are shown.

https://doi.org/10.1371/journal.pgen.1012096.s005

(TIF)

S5 Fig. Phosphomutants of GlmR are functionally similar to WT.

(A) Spot titer assay of WT (PY79), ∆glmR (SK35), ∆glmR glmR+ (SK56), ∆glmR glmR-T304A+ (SK139), and ∆glmR glmR-T304E+ (SK140) on LA, LA + 1 mM IPTG, DS, and DS + 1 mM IPTG. (B) Micrographs of WT (PY79), ∆glmR (SK35), ∆glmR glmR+ (SK56), ∆glmR glmR-T304A+ (SK139), and ∆glmR glmR-T304E+ (SK140) with or without 1 mM IPTG induction. (C) Cell width quantifications of ∆glmR glmR+ (SK56), ∆glmR glmR-T304A+ (SK139), and ∆glmR glmR-T304E+ (SK140). (D) Colony area measurements relative to uninduced ∆glmR glmR+ (SK56), ∆glmR glmR-T304A+ (SK139), or ∆glmR glmR-T304E+ (SK140). Area measured via FIJI automatically using thresholding. One-way ANOVA with Tukey’s correction was used for interpreting statistical significance; * = p < 0.05, ** = p < 0.01, ns = p > 0.05.

https://doi.org/10.1371/journal.pgen.1012096.s006

(TIF)

S6 Fig. Addendum to the working model.

(A) As described in Fig 8, UDP-GlcNAc produced by GlmR and GlmU enzymes is consumed through the pathways involving MreB, MreBH, Mbl, and PBP1 in WT cells. In the absence of MreB, hyperactive PBP1 leads to abnormal cell bulging. This consequence is averted by either deletion of pbp1 or overexpression of glmR (depicted in Fig 1B). When PBP1 is absent, alternative sigma factor SigI is activated which in turn upregulates mreBH. Therefore, the combined action of MreB and MreBH involved in cell width control leads to decreased cell width. In cells lacking mbl, UDP-GlcNAc utilization happens through both MreB and PBP1 pathways which result in twisted cell morphology. Thus, either deletion of glmR (lowers UDP GlcNAc level) or pbp1 (increases MreBH activity) restores viability. (B) In cells lacking glmR, MreB pathway is weakened and PBP1 becomes hyperactivated. This leads to cell shape abnormality. Thus, either overexpression of mreB or deletion of pbp1 results in cell morphology correction. Weak and strong UDP-GlcNAc consumption are represented with dashed and thicker arrows respectively.

https://doi.org/10.1371/journal.pgen.1012096.s007

(TIF)

S1 Video. Aberrant positioning of cytokinetic machinery in the absence of GlmR.

This Z-stack video shows ∆glmR (SK35) cell undergoing abnormal septation. Red, FM 4–64 membrane dye. Movie created in FIJI.

https://doi.org/10.1371/journal.pgen.1012096.s008

(MP4)

Acknowledgments

We thank the members of our laboratory for comments on the manuscript.

References

  1. 1. Pisithkul T, Patel NM, Amador-Noguez D. Post-translational modifications as key regulators of bacterial metabolic fluxes. Curr Opin Microbiol. 2015;24:29–37. pmid:25597444
  2. 2. Young MK, Wang JD. From dusty shelves toward the spotlight: growing evidence for Ap4A as an alarmone in maintaining RNA stability and proteostasis. Curr Opin Microbiol. 2024;81:102536. pmid:39216180
  3. 3. Stülke J, Grüppen A, Bramkamp M, Pelzer S. Bacillus subtilis, a Swiss Army Knife in Science and Biotechnology. J Bacteriol. 2023;205(5):e0010223. pmid:37140386
  4. 4. Tam NKM, Uyen NQ, Hong HA, Duc LH, Hoa TT, Serra CR, et al. The intestinal life cycle of Bacillus subtilis and close relatives. J Bacteriol. 2006;188(7):2692–700. pmid:16547057
  5. 5. Ettoumi B, Raddadi N, Borin S, Daffonchio D, Boudabous A, Cherif A. Diversity and phylogeny of culturable spore-forming Bacilli isolated from marine sediments. J Basic Microbiol. 2009;49 Suppl 1:S13-23. pmid:19322832
  6. 6. Vadia S, Levin PA. Growth rate and cell size: a re-examination of the growth law. Curr Opin Microbiol. 2015;24:96–103. pmid:25662920
  7. 7. Sperber AM, Herman JK. Metabolism Shapes the Cell. J Bacteriol. 2017;199(11):e00039-17. pmid:28320879
  8. 8. Galinier A, Foulquier E, Pompeo F. Metabolic Control of Cell Elongation and Cell Division in Bacillus subtilis. Front Microbiol. 2021;12:697930. pmid:34248920
  9. 9. Sachla AJ, Helmann JD. Resource sharing between central metabolism and cell envelope synthesis. Curr Opin Microbiol. 2021;60:34–43. pmid:33581378
  10. 10. Galinier A, Delan-Forino C, Foulquier E, Lakhal H, Pompeo F. Recent Advances in Peptidoglycan Synthesis and Regulation in Bacteria. Biomolecules. 2023;13(5).
  11. 11. Foulquier E, Pompeo F, Freton C, Cordier B, Grangeasse C, Galinier A. PrkC-mediated phosphorylation of overexpressed YvcK protein regulates PBP1 protein localization in Bacillus subtilis mreB mutant cells. J Biol Chem. 2014;289(34):23662–9. pmid:25012659
  12. 12. Patel V, Wu Q, Chandrangsu P, Helmann JD. A metabolic checkpoint protein GlmR is important for diverting carbon into peptidoglycan biosynthesis in Bacillus subtilis. PLoS Genet. 2018;14(9):e1007689. pmid:30248093
  13. 13. Görke B, Foulquier E, Galinier A. YvcK of Bacillus subtilis is required for a normal cell shape and for growth on Krebs cycle intermediates and substrates of the pentose phosphate pathway. Microbiology (Reading). 2005;151(Pt 11):3777–91. pmid:16272399
  14. 14. Kepplinger B, Wen X, Tyler AR, Kim B-Y, Brown J, Banks P, et al. Mirubactin C rescues the lethal effect of cell wall biosynthesis mutations in Bacillus subtilis. Front Microbiol. 2022;13:1004737. pmid:36312962
  15. 15. Tesson B, Dajkovic A, Keary R, Marlière C, Dupont-Gillain CC, Carballido-López R. Magnesium rescues the morphology of Bacillus subtilis mreB mutants through its inhibitory effect on peptidoglycan hydrolases. Sci Rep. 2022;12(1):1137. pmid:35064120
  16. 16. Wilson SA, Tank RKJ, Hobbs JK, Foster SJ, Garner EC. An exhaustive multiple knockout approach to understanding cell wall hydrolase function in Bacillus subtilis. mBio. 2023;14(5):e0176023. pmid:37768080
  17. 17. Kawai Y, Kawai M, Mackenzie ES, Dashti Y, Kepplinger B, Waldron KJ, et al. On the mechanisms of lysis triggered by perturbations of bacterial cell wall biosynthesis. Nat Commun. 2023;14(1):4123. pmid:37433811
  18. 18. Wendel BM, Pi H, Krüger L, Herzberg C, Stülke J, Helmann JD. A Central Role for Magnesium Homeostasis during Adaptation to Osmotic Stress. mBio. 2022;13(1):e0009222. pmid:35164567
  19. 19. Foulquier E, Pompeo F, Bernadac A, Espinosa L, Galinier A. The YvcK protein is required for morphogenesis via localization of PBP1 under gluconeogenic growth conditions in Bacillus subtilis. Mol Microbiol. 2011;80(2):309–18. pmid:21320184
  20. 20. Carballido-López R. The bacterial actin-like cytoskeleton. Microbiol Mol Biol Rev. 2006;70(4):888–909. pmid:17158703
  21. 21. Kawai Y, Daniel RA, Errington J. Regulation of cell wall morphogenesis in Bacillus subtilis by recruitment of PBP1 to the MreB helix. Mol Microbiol. 2009;71(5):1131–44. pmid:19192185
  22. 22. Dion MF, Kapoor M, Sun Y, Wilson S, Ryan J, Vigouroux A, et al. Bacillus subtilis cell diameter is determined by the opposing actions of two distinct cell wall synthetic systems. Nat Microbiol. 2019;4(8):1294–305. pmid:31086310
  23. 23. Middlemiss S, Blandenet M, Roberts DM, McMahon A, Grimshaw J, Edwards JM, et al. Molecular motor tug-of-war regulates elongasome cell wall synthesis dynamics in Bacillus subtilis. Nat Commun. 2024;15(1):5411. pmid:38926336
  24. 24. Lou Y, Woodson SA. Co-transcriptional folding of the glmS ribozyme enables a rapid response to metabolite. Nucleic Acids Res. 2024;52(2):872–84. pmid:38000388
  25. 25. McCarthy TJ, Plog MA, Floy SA, Jansen JA, Soukup JK, Soukup GA. Ligand requirements for glmS ribozyme self-cleavage. Chem Biol. 2005;12(11):1221–6. pmid:16298301
  26. 26. Watson PY, Fedor MJ. The glmS riboswitch integrates signals from activating and inhibitory metabolites in vivo. Nat Struct Mol Biol. 2011;18(3):359–63. pmid:21317896
  27. 27. Winkler WC, Nahvi A, Roth A, Collins JA, Breaker RR. Control of gene expression by a natural metabolite-responsive ribozyme. Nature. 2004;428(6980):281–6. pmid:15029187
  28. 28. Roth A, Nahvi A, Lee M, Jona I, Breaker RR. Characteristics of the glmS ribozyme suggest only structural roles for divalent metal ions. RNA. 2006;12(4):607–19. pmid:16484375
  29. 29. Litzinger S, Duckworth A, Nitzsche K, Risinger C, Wittmann V, Mayer C. Muropeptide rescue in Bacillus subtilis involves sequential hydrolysis by beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase. J Bacteriol. 2010;192(12):3132–43. pmid:20400549
  30. 30. Foulquier E, Pompeo F, Byrne D, Fierobe H-P, Galinier A. Uridine diphosphate N-acetylglucosamine orchestrates the interaction of GlmR with either YvcJ or GlmS in Bacillus subtilis. Sci Rep. 2020;10(1):15938. pmid:32994436
  31. 31. Pensinger DA, Gutierrez KV, Smith HB, Vincent WJB, Stevenson DS, Black KA, et al. Listeria monocytogenes GlmR Is an Accessory Uridyltransferase Essential for Cytosolic Survival and Virulence. mBio. 2023;14(2):e0007323. pmid:36939339
  32. 32. Pham TH, Liang Z-X, Marcellin E, Turner MS. Replenishing the cyclic-di-AMP pool: regulation of diadenylate cyclase activity in bacteria. Curr Genet. 2016;62(4):731–8. pmid:27074767
  33. 33. Zhu Y, Pham TH, Nhiep THN, Vu NMT, Marcellin E, Chakrabortti A, et al. Cyclic-di-AMP synthesis by the diadenylate cyclase CdaA is modulated by the peptidoglycan biosynthesis enzyme GlmM in Lactococcus lactis. Mol Microbiol. 2016;99(6):1015–27. pmid:26585449
  34. 34. Tosi T, Hoshiga F, Millership C, Singh R, Eldrid C, Patin D, et al. Inhibition of the Staphylococcus aureus c-di-AMP cyclase DacA by direct interaction with the phosphoglucosamine mutase GlmM. PLoS Pathog. 2019;15(1):e1007537. pmid:30668586
  35. 35. Gibhardt J, Heidemann JL, Bremenkamp R, Rosenberg J, Seifert R, Kaever V, et al. An extracytoplasmic protein and a moonlighting enzyme modulate synthesis of c-di-AMP in Listeria monocytogenes. Environ Microbiol. 2020;22(7):2771–91. pmid:32250026
  36. 36. Pathania M, Tosi T, Millership C, Hoshiga F, Morgan RML, Freemont PS, et al. Structural basis for the inhibition of the Bacillus subtilis c-di-AMP cyclase CdaA by the phosphoglucomutase GlmM. J Biol Chem. 2021;297(5):101317. pmid:34678313
  37. 37. Foster AJ, Li H, Drougkas P, Schuurman-Wolters GK, Ten Kate J, Paulino C, et al. Membrane-embedded CdaA is required for efficient synthesis of second messenger cyclic di-AMP. Commun Biol. 2024;7(1):1710. pmid:39739009
  38. 38. Foulquier E, Galinier A. YvcK, a protein required for cell wall integrity and optimal carbon source utilization, binds uridine diphosphate-sugars. Sci Rep. 2017;7(1):4139. pmid:28646159
  39. 39. Libby EA, Goss LA, Dworkin J. The Eukaryotic-Like Ser/Thr Kinase PrkC Regulates the Essential WalRK Two-Component System in Bacillus subtilis. PLoS Genet. 2015;11(6):e1005275. pmid:26102633
  40. 40. Zheng CR, Singh A, Libby A, Silver PA, Libby EA. Modular and Single-Cell Sensors of Bacterial Ser/Thr Kinase Activity. ACS Synth Biol. 2021;10(9):2340–50. pmid:34463482
  41. 41. Sun Y, Hürlimann S, Garner E. Growth rate is modulated by monitoring cell wall precursors in Bacillus subtilis. Nat Microbiol. 2023;8(3):469–80. pmid:36797487
  42. 42. Carabetta VJ, Greco TM, Tanner AW, Cristea IM, Dubnau D. Temporal Regulation of the Bacillus subtilis Acetylome and Evidence for a Role of MreB Acetylation in Cell Wall Growth. mSystems. 2016;1(3).
  43. 43. Reverdy A, Chen Y, Hunter E, Gozzi K, Chai Y. Protein lysine acetylation plays a regulatory role in Bacillus subtilis multicellularity. PLoS One. 2018;13(9):e0204687. pmid:30265683
  44. 44. Qin C, Graf LG, Striska K, Janetzky M, Geist N, Specht R, et al. Acetyl-CoA synthetase activity is enzymatically regulated by lysine acetylation using acetyl-CoA or acetyl-phosphate as donor molecule. Nat Commun. 2024;15(1):6002. pmid:39019872
  45. 45. Reuß DR, Commichau FM, Gundlach J, Zhu B, Stülke J. The Blueprint of a Minimal Cell: MiniBacillus. Microbiol Mol Biol Rev. 2016;80(4):955–87. pmid:27681641
  46. 46. Hering J, Dunevall E, Ek M, Brändén G. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis. Drug Discov Today. 2018;23(7):1426–35. pmid:29778697
  47. 47. Swoboda JG, Campbell J, Meredith TC, Walker S. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem. 2010;11(1):35–45. pmid:19899094
  48. 48. Tamura G, Sasaki T, Matsuhashi M, Takatsuki A, Yamasaki M. Tunicamycin Inhibits the Formation of Lipid Intermediate in Cell-free Peptidoglycan Synthesis of Bacteria. Agricultural and Biological Chemistry. 1976;40(2):447–9.
  49. 49. Barber F, Akbary Z, Yuan Z, Biboy J, Vollmer W, Rojas ER. Wall teichoic acids regulate peptidoglycan synthesis by paving cell wall nanostructure. bioRxiv. 2025.
  50. 50. Campbell J, Singh AK, Santa Maria JP Jr, Kim Y, Brown S, Swoboda JG, et al. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol. 2011;6(1):106–16. pmid:20961110
  51. 51. Price NP, Labeda DP, Naumann TA, Vermillion KE, Bowman MJ, Berhow MA, et al. Quinovosamycins: new tunicamycin-type antibiotics in which the alpha, beta-1’‘,11’-linked N-acetylglucosamine residue is replaced by N-acetylquinovosamine. J Antibiot (Tokyo). 2016;69(8):637–46.
  52. 52. Price NP, Hartman TM, Li J, Velpula KK, Naumann TA, Guda MR, et al. Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactams. J Antibiot (Tokyo). 2017;70(11):1070–7. pmid:28951601
  53. 53. Yamamoto K, Sato T, Mashalidis EH, Lee SY, Horiuchi M, Ichikawa S. Design, Synthesis, and Biological Evaluation of Lipid-Modified Derivatives of Tunicamycins. Chemistry. 2025;31(59):e02296.
  54. 54. Brown S, Santa Maria JP Jr, Walker S. Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol. 2013;67:313–36. pmid:24024634
  55. 55. Si F, Le Treut G, Sauls JT, Vadia S, Levin PA, Jun S. Mechanistic Origin of Cell-Size Control and Homeostasis in Bacteria. Curr Biol. 2019;29(11):1760-1770.e7. pmid:31104932
  56. 56. Nordholt N, van Heerden JH, Bruggeman FJ. Biphasic Cell-Size and Growth-Rate Homeostasis by Single Bacillus subtilis Cells. Curr Biol. 2020;30(12):2238-2247.e5. pmid:32413303
  57. 57. Guo T, Herman JK. Magnesium Modulates Bacillus subtilis Cell Division Frequency. J Bacteriol. 2023;205(1):e0037522. pmid:36515540
  58. 58. Commichau FM, Heidemann JL, Ficner R, Stülke J. Making and Breaking of an Essential Poison: the Cyclases and Phosphodiesterases That Produce and Degrade the Essential Second Messenger Cyclic di-AMP in Bacteria. J Bacteriol. 2018;201(1):e00462-18. pmid:30224435
  59. 59. Gundlach J, Mehne FMP, Herzberg C, Kampf J, Valerius O, Kaever V, et al. An Essential Poison: Synthesis and Degradation of Cyclic Di-AMP in Bacillus subtilis. J Bacteriol. 2015;197(20):3265–74. pmid:26240071
  60. 60. Luo Y, Helmann JD. Analysis of the role of Bacillus subtilis σ(M) in β-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol Microbiol. 2012;83(3):623–39. pmid:22211522
  61. 61. Mehne FMP, Gunka K, Eilers H, Herzberg C, Kaever V, Stülke J. Cyclic di-AMP homeostasis in bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. J Biol Chem. 2013;288(3):2004–17. pmid:23192352
  62. 62. Patel V, Black KA, Rhee KY, Helmann JD. Bacillus subtilis PgcA moonlights as a phosphoglucosamine mutase in support of peptidoglycan synthesis. PLoS Genet. 2019;15(10):e1008434. pmid:31589605
  63. 63. Nelson JW, Sudarsan N, Furukawa K, Weinberg Z, Wang JX, Breaker RR. Riboswitches in eubacteria sense the second messenger c-di-AMP. Nat Chem Biol. 2013;9(12):834–9. pmid:24141192
  64. 64. Ren A, Patel DJ. c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets. Nat Chem Biol. 2014;10(9):780–6. pmid:25086509
  65. 65. Gao A, Serganov A. Structural insights into recognition of c-di-AMP by the ydaO riboswitch. Nat Chem Biol. 2014;10(9):787–92. pmid:25086507
  66. 66. Kviatkovski I, Zhong Q, Vaidya S, Gründling A. Identification of novel genetic factors that regulate c-di-AMP production in Staphylococcus aureus using a riboswitch-based biosensor. mSphere. 2024;9(10):e0032124. pmid:39287429
  67. 67. Brogan AP, Bardetti P, Rojas ER, Rudner DZ. Cyclic-di-AMP modulates cellular turgor in response to defects in bacterial cell wall synthesis. Nat Microbiol. 2025;10(7):1698–710. pmid:40528006
  68. 68. Oppenheimer-Shaanan Y, Wexselblatt E, Katzhendler J, Yavin E, Ben-Yehuda S. c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep. 2011;12(6):594–601. pmid:21566650
  69. 69. Townsley L, Yannarell SM, Huynh TN, Woodward JJ, Shank EA. Cyclic di-AMP acts as an extracellular signal that impacts Bacillus subtilis biofilm formation and plant attachment. mBio. 2018;9(2).
  70. 70. Abundiz-Yañez K, Leyva-Sánchez HC, Robleto EA, Pedraza-Reyes M. Stress-Associated and Growth-Dependent Mutagenesis Are Divergently Regulated by c-di-AMP Levels in Bacillus subtilis. Int J Mol Sci. 2022;24(1):455. pmid:36613897
  71. 71. Nicolas P, Mäder U, Dervyn E, Rochat T, Leduc A, Pigeonneau N, et al. Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis. Science. 2012;335(6072):1103–6. pmid:22383849
  72. 72. Elfmann C, Dumann V, van den Berg T, Stülke J. A new framework for SubtiWiki, the database for the model organism Bacillus subtilis. Nucleic Acids Res. 2025;53(D1):D864–70. pmid:39441067
  73. 73. Sasaki T, Yamasaki M, Takatsuki A, Tamura G. Accumulation of cell-bound alpha-amylase in Bacillus subtilis cells in the presence of tunicamycin. Biochem Biophys Res Commun. 1980;92(1):334–41. pmid:6153524
  74. 74. Bhattacharya D, King A, McKnight L, Horigian P, Eswara PJ. GpsB interacts with FtsZ in multiple species and may serve as an accessory Z-ring anchor. Mol Biol Cell. 2025;36(1):ar10. pmid:39602291
  75. 75. Kosono S, Tamura M, Suzuki S, Kawamura Y, Yoshida A, Nishiyama M, et al. Changes in the Acetylome and Succinylome of Bacillus subtilis in Response to Carbon Source. PLoS One. 2015;10(6):e0131169. pmid:26098117
  76. 76. Zhang M, Liu T, Wang L, Huang Y, Fan R, Ma K, et al. Global landscape of lysine acylomes in Bacillus subtilis. J Proteomics. 2023;271:104767. pmid:36336260
  77. 77. Rizo J, Encarnación-Guevara S. Bacterial protein acetylation: mechanisms, functions, and methods for study. Front Cell Infect Microbiol. 2024;14:1408947. pmid:39027134
  78. 78. Mir M, Prisic S, Kang C-M, Lun S, Guo H, Murry JP, et al. Mycobacterial gene cuvA is required for optimal nutrient utilization and virulence. Infect Immun. 2014;82(10):4104–17. pmid:25047842
  79. 79. Pensinger DA, Boldon KM, Chen GY, Vincent WJB, Sherman K, Xiong M, et al. The Listeria monocytogenes PASTA Kinase PrkA and Its Substrate YvcK Are Required for Cell Wall Homeostasis, Metabolism, and Virulence. PLoS Pathog. 2016;12(11):e1006001. pmid:27806131
  80. 80. Djorić D, Atkinson SN, Kristich CJ. Reciprocal regulation of enterococcal cephalosporin resistance by products of the autoregulated yvcJ-glmR-yvcL operon enhances fitness during cephalosporin exposure. PLoS Genet. 2024;20(3):e1011215. pmid:38512984
  81. 81. Kawai Y, Asai K, Errington J. Partial functional redundancy of MreB isoforms, MreB, Mbl and MreBH, in cell morphogenesis of Bacillus subtilis. Mol Microbiol. 2009;73(4):719–31. pmid:19659933
  82. 82. Domínguez-Cuevas P, Porcelli I, Daniel RA, Errington J. Differentiated roles for MreB-actin isologues and autolytic enzymes in Bacillus subtilis morphogenesis. Mol Microbiol. 2013;89(6):1084–98. pmid:23869552
  83. 83. Sassine J, Sousa J, Lalk M, Daniel RA, Vollmer W. Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis. Sci Rep. 2020;10(1):17910. pmid:33087775
  84. 84. Koo BM, Todor H, Sun J, van Gestel J, Hawkins JS, Hearne CC. Comprehensive double-mutant analysis of the Bacillus subtilis envelope using double-CRISPRi. bioRxiv. 2024.
  85. 85. Patel Y, Zhao H, Helmann JD. A regulatory pathway that selectively up-regulates elongasome function in the absence of class A PBPs. Elife. 2020;9.
  86. 86. Schirner K, Errington J. The cell wall regulator {sigma}I specifically suppresses the lethal phenotype of mbl mutants in Bacillus subtilis. J Bacteriol. 2009;191(5):1404–13. pmid:19114499
  87. 87. Abhayawardhane Y, Stewart GC. Bacillus subtilis possesses a second determinant with extensive sequence similarity to the Escherichia coli mreB morphogene. J Bacteriol. 1995;177(3):765–73. pmid:7836311
  88. 88. Jones LJ, Carballido-López R, Errington J. Control of cell shape in bacteria: helical, actin-like filaments in Bacillus subtilis. Cell. 2001;104(6):913–22. pmid:11290328
  89. 89. Chastanet A, Carballido-Lopez R. The actin-like MreB proteins in Bacillus subtilis: a new turn. Front Biosci (Schol Ed). 2012;4(4):1582–606. pmid:22652894
  90. 90. D’Elia MA, Millar KE, Beveridge TJ, Brown ED. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J Bacteriol. 2006;188(23):8313–6. pmid:17012386
  91. 91. Mirouze N, Ferret C, Cornilleau C, Carballido-López R. Antibiotic sensitivity reveals that wall teichoic acids mediate DNA binding during competence in Bacillus subtilis. Nat Commun. 2018;9(1):5072. pmid:30498236
  92. 92. Schirner K, Marles-Wright J, Lewis RJ, Errington J. Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. EMBO J. 2009;28(7):830–42. pmid:19229300
  93. 93. Guyet A, Alofi A, Daniel RA. Insights into the Roles of Lipoteichoic Acids and MprF in Bacillus subtilis. mBio. 2023;14(1):e0266722. pmid:36744964
  94. 94. Duan Y, Sperber AM, Herman JK. YodL and YisK Possess Shape-Modifying Activities That Are Suppressed by Mutations in Bacillus subtilis mreB and mbl. J Bacteriol. 2016;198(15):2074–88. pmid:27215790
  95. 95. Guo T, Sperber AM, Krieger IV, Duan Y, Chemelewski VR, Sacchettini JC, et al. Bacillus subtilis YisK possesses oxaloacetate decarboxylase activity and exhibits Mbl-dependent localization. J Bacteriol. 2024;206(1):e0020223. pmid:38047707
  96. 96. Osawa M, Erickson HP. Turgor Pressure and Possible Constriction Mechanisms in Bacterial Division. Front Microbiol. 2018;9:111. pmid:29445369
  97. 97. Nguyen LT, Oikonomou CM, Jensen GJ. Simulations of Proposed Mechanisms of FtsZ-Driven Cell Constriction. J Bacteriol. 2021;203(3):e00576-20. pmid:33199285
  98. 98. Willdigg JR, Patel Y, Helmann JD. A Decrease in Fatty Acid Synthesis Rescues Cells with Limited Peptidoglycan Synthesis Capacity. mBio. 2023;14(2):e0047523. pmid:37017514
  99. 99. Ramirez-Diaz DA, Yin L, Albanesi D, Zheng J, de Mendoza D, Garner EC. The interplay of membrane tension and FtsZ filament condensation on the initiation and progression of cell division in B. subtilis. eLife Sciences Publications, Ltd. 2025.
  100. 100. Galperin MY. All DACs in a Row: Domain Architectures of Bacterial and Archaeal Diadenylate Cyclases. J Bacteriol. 2023;205(4):e0002323. pmid:37022175
  101. 101. Stülke J, Krüger L. Cyclic di-AMP Signaling in Bacteria. Annu Rev Microbiol. 2020;74:159–79. pmid:32603625
  102. 102. Fuss MF, Wieferig J-P, Corey RA, Hellmich Y, Tascón I, Sousa JS, et al. Cyclic di-AMP traps proton-coupled K+ transporters of the KUP family in an inward-occluded conformation. Nat Commun. 2023;14(1):3683. pmid:37344476
  103. 103. Rocha R, Jorge JMP, Teixeira-Duarte CM, Figueiredo-Costa IR, Cereija TB, Ferreira-Teixeira PF, et al. c-di-AMP determines the hierarchical organization of bacterial RCK proteins. Proc Natl Acad Sci U S A. 2024;121(18):e2318666121. pmid:38652747
  104. 104. Whatmore AM, Chudek JA, Reed RH. The effects of osmotic upshock on the intracellular solute pools of Bacillus subtilis. J Gen Microbiol. 1990;136(12):2527–35. pmid:2127802
  105. 105. Dersch S, Graumann PL. Adaptation of Bacillus subtilis MreB Filaments to Osmotic Stress Depends on Influx of Potassium Ions. Microorganisms. 2024;12(7):1309.
  106. 106. Król E, Scheffers D-J. FtsZ polymerization assays: simple protocols and considerations. J Vis Exp. 2013;(81):e50844. pmid:24300445
  107. 107. Stautz J, Hellmich Y, Fuss MF, Silberberg JM, Devlin JR, Stockbridge RB, et al. Molecular Mechanisms for Bacterial Potassium Homeostasis. J Mol Biol. 2021;433(16):166968. pmid:33798529
  108. 108. Do EA, Gries CM. Beyond Homeostasis: Potassium and Pathogenesis during Bacterial Infections. Infect Immun. 2021;89(7):e0076620. pmid:33875474
  109. 109. Helmann JD. Metals in Motion: Understanding Labile Metal Pools in Bacteria. Biochemistry. 2025;64(2):329–45. pmid:39755956
  110. 110. Peterson BN, Young MKM, Luo S, Wang J, Whiteley AT, Woodward JJ, et al. (p)ppGpp and c-di-AMP Homeostasis Is Controlled by CbpB in Listeria monocytogenes. mBio. 2020;11(4):e01625-20. pmid:32843560
  111. 111. Krüger L, Herzberg C, Wicke D, Scholz P, Schmitt K, Turdiev A, et al. Sustained Control of Pyruvate Carboxylase by the Essential Second Messenger Cyclic di-AMP in Bacillus subtilis. mBio. 2021;13(1):e0360221. pmid:35130724
  112. 112. Krüger L, Herzberg C, Wicke D, Bähre H, Heidemann JL, Dickmanns A, et al. A meet-up of two second messengers: the c-di-AMP receptor DarB controls (p)ppGpp synthesis in Bacillus subtilis. Nat Commun. 2021;12(1):1210. pmid:33619274
  113. 113. Heidemann JL, Neumann P, Krüger L, Wicke D, Vinhoven L, Linden A, et al. Structural basis for c-di-AMP-dependent regulation of the bacterial stringent response by receptor protein DarB. J Biol Chem. 2022;298(7):102144. pmid:35714772
  114. 114. Patel Y, Helmann JD. A mutation in RNA polymerase imparts resistance to β-lactams by preventing dysregulation of amino acid and nucleotide metabolism. Cell Rep. 2025;44(2):115268. pmid:39908144
  115. 115. Wang M, Huang M, Gu H, Li S, Ma Y, Wang J. Mutational analysis to identify the residues essential for the acetyltransferase activity of GlmU in Bacillus subtilis. RSC Adv. 2017;7(23):13858–67.
  116. 116. Hove-Jensen B. Identification of tms-26 as an allele of the gcaD gene, which encodes N-acetylglucosamine 1-phosphate uridyltransferase in Bacillus subtilis. J Bacteriol. 1992;174(21):6852–6. pmid:1328164
  117. 117. Parikh A, Verma SK, Khan S, Prakash B, Nandicoori VK. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity. J Mol Biol. 2009;386(2):451–64. pmid:19121323
  118. 118. Eymann C, Homuth G, Scharf C, Hecker M. Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis. J Bacteriol. 2002;184(9):2500–20. pmid:11948165
  119. 119. Sojka L, Kouba T, Barvík I, Sanderová H, Maderová Z, Jonák J, et al. Rapid changes in gene expression: DNA determinants of promoter regulation by the concentration of the transcription initiating NTP in Bacillus subtilis. Nucleic Acids Res. 2011;39(11):4598–611. pmid:21303765
  120. 120. She F, Liu K, Anderson BW, Pisithkul T, Li Y, Fung DK, et al. Pyruvate kinase directly generates GTP in glycolysis, supporting growth and contributing to guanosine toxicity. mBio. 2025;16(4):e0379824. pmid:39998177
  121. 121. She F, Anderson BW, Khana DB, Zhang S, Steinchen W, Fung DK, et al. Allosteric regulation of pyruvate kinase enables efficient and robust gluconeogenesis by preventing metabolic conflicts and carbon overflow. mSystems. 2025;10(2):e0113124. pmid:39873491
  122. 122. Pederick JL, Kumar A, Pukala TL, Bruning JB. Functional and structural characterization of Staphylococcus aureus N-acetylglucosamine 1-phosphate uridyltransferase (GlmU) reveals a redox-sensitive acetyltransferase activity. Protein Sci. 2025;34(4):e70111. pmid:40143772
  123. 123. Gaballa A, Newton GL, Antelmann H, Parsonage D, Upton H, Rawat M, et al. Biosynthesis and functions of bacillithiol, a major low-molecular-weight thiol in Bacilli. Proc Natl Acad Sci U S A. 2010;107(14):6482–6. pmid:20308541
  124. 124. Pompeo F, Byrne D, Mengin-Lecreulx D, Galinier A. Dual regulation of activity and intracellular localization of the PASTA kinase PrkC during Bacillus subtilis growth. Sci Rep. 2018;8(1):1660. pmid:29374241
  125. 125. Carr RA, Tucker T, Newman PM, Jadalla L, Jaludi K, Reid BE, et al. Nε-lysine acetylation of the histone-like protein HBsu influences antibiotic survival and persistence in Bacillus subtilis. Front Microbiol. 2024;15:1356733. pmid:38835483
  126. 126. Burckhardt RM, Escalante-Semerena JC. Sirtuin-dependent reversible lysine acetylation of the o-succinylbenzoyl-coenzyme A synthetase of Bacillus subtilis. Microbiol Spectr. 2024;12(12):e0201124. pmid:39422507
  127. 127. Zheng L, Du Y, Steinchen W, Girbig M, Abendroth F, Jalomo-Khayrova E, et al. Regulation of acetyl-CoA biosynthesis via an intertwined acetyl-CoA synthetase/acetyltransferase complex. Nat Commun. 2025;16(1):2557. pmid:40089509
  128. 128. Richard-Greenblatt M, Av-Gay Y. Epigenetic phosphorylation control of Mycobacterium tuberculosis infection and persistence. Microbiol Spectr. 2017;5(2).
  129. 129. Reed P, Sorg M, Alwardt D, Serra L, Veiga H, Schäper S, et al. A CRISPRi-based genetic resource to study essential Staphylococcus aureus genes. mBio. 2024;15(1):e0277323. pmid:38054745
  130. 130. Chaudhuri RR, Allen AG, Owen PJ, Shalom G, Stone K, Harrison M, et al. Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics. 2009;10:291. pmid:19570206
  131. 131. Santiago M, Matano LM, Moussa SH, Gilmore MS, Walker S, Meredith TC. A new platform for ultra-high density Staphylococcus aureus transposon libraries. BMC Genomics. 2015;16(1):252. pmid:25888466
  132. 132. Liang C, Rios-Miguel AB, Jarick M, Neurgaonkar P, Girard M, François P, et al. Staphylococcus aureus Transcriptome Data and Metabolic Modelling Investigate the Interplay of Ser/Thr Kinase PknB, Its Phosphatase Stp, the glmR/yvcK Regulon and the cdaA Operon for Metabolic Adaptation. Microorganisms. 2021;9(10):2148.
  133. 133. Molina-Quiroz RC, Lazinski DW, Camilli A, Levy SB. Transposon-Sequencing Analysis Unveils Novel Genes Involved in the Generation of Persister Cells in Uropathogenic Escherichia coli. Antimicrob Agents Chemother. 2016;60(11):6907–10. pmid:27550350
  134. 134. El Qaidi S, Scott NE, Hays MP, Hardwidge PR. Arginine glycosylation regulates UDP-GlcNAc biosynthesis in Salmonella enterica. Sci Rep. 2022;12(1):5293. pmid:35351940
  135. 135. Bremer E, Calteau A, Danchin A, Harwood C, Helmann JD, Médigue C, et al. A model industrial workhorse: Bacillus subtilis strain 168 and its genome after a quarter of a century. Microb Biotechnol. 2023;16(6):1203–31. pmid:37002859
  136. 136. Rani C, Khan IA. UDP-GlcNAc pathway: potential target for inhibitor discovery against M. tuberculosis. Eur J Pharm Sci. 2016;83:62–70.
  137. 137. Han X, Chen C, Wang H, Kang J, Yan Q, Ma Y, et al. GlmU inhibitor from the roots of Euphorbia ebracteolata as an anti-tuberculosis agent. RSC Adv. 2022;12(28):18266–73. pmid:35800323
  138. 138. Wyllie JA, McKay MV, Barrow AS, Soares da Costa TP. Biosynthesis of uridine diphosphate N-acetylglucosamine: An underexploited pathway in the search for novel antibiotics?. IUBMB Life. 2022;74(12):1232–52.
  139. 139. Silkenath B, Kläge D, Altwein H, Schmidhäuser N, Mayer G, Hartig JS, et al. Phosphonate and Thiasugar Analogues of Glucosamine-6-phosphate: Activation of the glmS Riboswitch and Antibiotic Activity. ACS Chem Biol. 2023;18(10):2324–34. pmid:37793187
  140. 140. Youngman P, Perkins JB, Losick R. Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene. Plasmid. 1984;12(1):1–9. pmid:6093169
  141. 141. Koo B-M, Kritikos G, Farelli JD, Todor H, Tong K, Kimsey H, et al. Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis. Cell Syst. 2017;4(3):291-305.e7. pmid:28189581
  142. 142. Guérout-Fleury AM, Frandsen N, Stragier P. Plasmids for ectopic integration in Bacillus subtilis. Gene. 1996;180(1–2):57–61. pmid:8973347
  143. 143. Wozniak KJ, Simmons LA. Genome Editing Methods for Bacillus subtilis. Methods Mol Biol. 2022;2479:159–74. pmid:35583738
  144. 144. Popp PF, Dotzler M, Radeck J, Bartels J, Mascher T. The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis. Sci Rep. 2017;7(1):15058. pmid:29118374
  145. 145. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. pmid:22743772
  146. 146. Brzozowski RS, White ML, Eswara PJ. Live-Cell Fluorescence Microscopy to Investigate Subcellular Protein Localization and Cell Morphology Changes in Bacteria. J Vis Exp. 2019;153.